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ABSTRACT OF DISSERTATION

MULTIMODAL NONCONTACT DIFFUSE OPTICAL REFLECTANCE IMAGING
OF BLOOD FLOW AND FLUORESCENCE CONTRASTS
In this study we design a succession of three increasingly adept diffuse optical
devices towards the simultaneous 3D imaging of blood flow and fluorescence
contrasts in relatively deep tissues. These metrics together can provide future
insights into the relationship between blood flow distributions and fluorescent or
fluorescently tagged agents. A noncontact diffuse correlation tomography (ncDCT)
device was firstly developed to recover flow by mechanically scanning a lensbased apparatus across the sample. The novel flow reconstruction technique and
measuring boundary curvature were advanced in tandem. The establishment of
CCD camera detection with a high sampling density and flow recovery by speckle
contrast followed with the next instrument, termed speckle contrast diffuse
correlation tomography (scDCT). In scDCT, an optical switch sequenced coherent
near-infrared light into contact-based source fibers around the sample surface. A
fully noncontact reflectance mode device finalized improvements by combining
noncontact scDCT (nc_scDCT) and diffuse fluorescence tomography (DFT)
techniques. In the combined device, a galvo-mirror directed polarized light to the
sample surface. Filters and a cross polarizer in stackable tubes promoted
extracting flow indices, absorption coefficients, and fluorescence concentrations
(indocyanine green, ICG). The scDCT instrumentation was validated through
detection of a cubical solid tissue-like phantom heterogeneity beneath a liquid
phantom (background) surface where recovery of its center and dimensions
agreed with the known values. The combined nc_scDCT/DFT identified both a
cubical solid phantom and a tube of stepwise varying ICG concentration
(absorption and fluorescence contrast). The tube imaged by nc_scDCT/DFT
exhibited expected trends in absorption and fluorescence. The tube shape,
orientation, and localization were recovered in general agreement with actuality.
The flow heterogeneity localization was successfully extracted and its average
relative flow values in agreement with previous studies. Increasing ICG
concentrations induced notable disturbances in the tube region (≥ 0.25 μM/1 μM
for 785 nm/830 nm) suggesting the graduating absorption (320% increase at 785
nm) introduced errors. We observe that 830 nm is lower in the ICG absorption

spectrum and the correspondingly measured flow encountered less influence than
785 nm. From these results we anticipate the best practice in future studies to be
utilization of a laser source with wavelength in a low region of the ICG absorption
spectrum (e.g., 830 nm) or to only monitor flow prior to ICG injection or postclearance. In addition, ncDCT was initially tested in a mouse tumor model to
examine tumor size and averaged flow changes over a four-day interval. The next
steps in forwarding the combined device development include the straightforward
automation of data acquisition and filter rotation and applying it to in vivo tumor
studies. These animal/clinical models may seek information such as simultaneous
detection of tumor flow, fluorescence, and absorption contrasts or analyzing the
relationship between variably sized fluorescently tagged nanoparticles and their
tumor deposition relationship to flow distributions.

KEYWORDS: Speckle Contrast Diffuse Correlation Tomography (scDCT),
Noncontact Diffuse Correlation Tomography (ncDCT), Blood Flow,
Fluorescence, Multimodal Imaging
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CHAPTER 1 INTRODUCTION

1.1 Blood Flow and Fluorescence in Cancer Research

Blood flow and its response to physiological changes can serve as a status
indicator into underlying tissue microenvironment conditions. Many diseased and
abnormal progressions manifest through functional presentation as well as, or
even prior to, observable structural alterations. Thus, monitoring the blood flow can
provide supporting information to medical professionals in the detection, diagnosis,
and treatment of patients. It may also serve in early studies on small animals which
seek to gain, for example, insights into disease mechanisms and the effectiveness
of treatments. One of the most prevalent objectives in flow studies is then to
observe the contrast in flow between healthy and abnormal tissues which can help
characterize diseases such as cancer.
Specifically, the microenvironment of cancerous tissues is distinguishable from
healthy tissues by its highly irregular and chaotic vascular network. The feature of
induced angiogenesis has been identified as one of the hallmarks of cancer [1].
How this overarching observation originates and presents in specific cases varies
widely. A summarization of reported intertumoral blood flows in human
malignancies and healthy tissues highlights upon the disparities; for example,
squamous cell carcinoma breast cancer blood flow was found to range from ~0.07
– 0.40 ml/g/min compared to the mean healthy lactating and post-menopausal
breast of 0.80 and 0.04 ml/g/min respectively [2]. The linking of increased
angiogenesis and blood flow has been reported [3, 4]. Furthermore, tumor
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vascularity as evaluated by mean arteriole number has been shown to exhibit a 3fold increase in carcinomas [4]. Intratumoral variations frequently occur due to the
unregulated

growth

and

cellular

proliferation

accompanied

by

other

microenvironmental alterations. Hypoxic and necrotic tissue regions can form in
unpredictable fashion as nutrient transport is inhibited by perfunctory vessel
networks and the collapse of vessels due to rising interstitial pressures [2].
Fluorescing agents also play a role of great medical interest, especially in
cancer studies. One of the biggest impediments to cancer treatment is the ability
to penetrate and effectively deliver drugs or other factors throughout a solid tumor.
Adequate drug delivery and targeting of tumor tissues then largely governs
treatment success [5-10]. Some studies rely on the enhanced permeability and
retention (EPR) effect [11]. The injection of drugs is expected under EPR
circumstances to preferentially accumulate in the leaky tumor vasculature. This
behavior is extended to the injection of fluorescent agents for localizing in and
demarcating tumor tissues. Though useful, the EPR assumption is not ideal and
much current research into increasing control has taken the direction of
nanotechnology, including the labeling of nanoparticles with fluorescence [12].
Nanoparticles provide a robust framework for leveraging receptor targeting,
polymorphic adaptations, and drug loading and are expected to become an
essential part of cancer therapy. It is anticipated that multipurpose nanoparticle
designs can tailor treatments in innovative ways to the unique features of different
cancers, location, and subject.

2

1.2 Medical Imaging and Diffuse Optics

Contemporary medical imaging options are numerous as is evinced by
perusing any modern healthcare facilities’ list of imaging services. These may be
practically differentiated by the nature of their probe such as acoustic waves
(Ultrasound, Doppler Ultrasound) and electromagnetic radiation as x-rays
(Projection Radiography, Mammography, Computed Tomography, Fluoroscopy),
visible light (Optical Coherence Tomography, Laser Speckle Contrast Imaging,
Laser Doppler), radiofrequency (Magnetic Resonance Imaging, Functional
Magnetic Resonance Imaging/Blood-Oxygen-Level Dependent Contrast Imaging,
Magnetic Resonance Angiography), and injectable emitters of gamma rays
(nuclear imaging; Positron Emission Tomography, Stimulated Positron Emission
Computed Tomography). The latitudes in making an appropriate selection depend
on many factors including the type of information recoverable, tissue type
applicability (i.e., brain, muscle), safety, hardware and operating costs, and time
and convenience (i.e., image acquisition duration, real-time vs. delayed results).
Near-infrared (NIR; 650-900 nm) light has gained growing contemporary popularity
among medical imaging modalities with its clinically preferential safety (e.g.,
nonionizing radiation), noninvasiveness, sensitivity to physiological processes in
deep tissues (several centimeters), relative low cost in the realm of clinical imaging
instrumentation, and potential for portable bedside measurements.
Advances over the last two centuries have set the foundation for modern NIR
optics and tomography including the development of appropriate theories and
observations (i.e., statistical physics, wave-particle duality, radiative transfer), and
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available tools/technology (i.e., fast and efficient algorithms, modeling software,
computing resources, lasers, sensitive light detectors). Less than two decades
after the advent of the laser around 1960, an “NIR Window” (Figure 1.1) was
distinguished (though recognition of optical transmission in tissue existed prior
[13]) whereby biological tissues present low optical absorption and high scattering
allowing measurement of oxygenated hemoglobin and deoxygenated hemoglobin
concentrations

(tissue

oxygenation)

[14].

The

current

diffuse

optical

instrumentation stemming from this collective keystone are diverse. Systems may
be separated by use of continuous-wave (CW; intensity), frequency-domain (FD;
amplitude and phase), or time-domain (TD; temporal point spread function)
paradigms which inherently envelopes their measurables and dictates system
design. Prioritizing transillumination or reflectance signals further dichotomizes
their suitable applications. The systems may focus on spectroscopy or imaging,
the latter typically the most desirable and consequently complex.

4

Figure 1.1: The near-infrared window. The molar extinction coefficient
demonstrates low light absorption characteristics of the common intrinsic
absorbing

tissue

chromophores:

oxygenated

hemoglobin,

HbO2,

and

deoxygenated hemoglobin, Hb.

The properties of light in the NIR spectrum and its interactions with biological
tissues offer many options for extracting useful information depending on the
particular feature of light and type of tissue such as angiogenesis, biochemical
information, metabolism, and scatterer size distributions [14, 15]. In this study, we
restrict ourselves to CW systems which are the simplest and most economical
paradigm. We incorporate three diffuse optical imaging modalities capable of
extracting unique sets of information, namely diffuse optical spectroscopy and
tomography (DOS/DOT) for absorption, diffuse fluorescence spectroscopy and
tomography (DFS/DFT; also known as diffuse optical fluorescence tomography

5

DOFT) for fluorophore concentration, and diffuse correlation spectroscopy and
tomography (DCS/DCT) for blood flow changes.
These diffuse optical techniques have proven successful in cancer research
investigations. For example, absorption contrasts, enhanced by indocyanine green
(ICG) and measured by DOT, identified cancerous tissues (e.g., ductal carcinoma,
fibroadenoma) and a non-specific heterogeneous distribution for healthy tissues
(e.g., no disease) in the human breast [16]. These results were validated against
Gadolinium (Gd)-enhanced MRI images. The fluorescent signal contrasts of ICG
have also been measured by DFT in separating healthy and diseased human
breast tissues (e.g., invasive carcinomas), validated against Gd-enhanced MRI
[17]. Sufficient temporal resolution enables using absorption and/or concentration
information to examine the ICG pharmacokinetics [18]. The simultaneous
monitoring of absorption and fluorescence changes has already been methodically
compared to determine the optimal acquisition arrangement (under FD
considerations) [19]. A DCT-based device, validated by ultrasound (US), exhibited
that it too has the potential to differentiate healthy and abnormal breast tissues
(e.g., ductal papilloma and low-grade adenocarcinoma, atypical ductal hyperplasia
and low-grade carcinoma) through presentations of blood flow heterogeneities
[20]. The combination of tissue hemodynamic parameters as recovered by diffuse
optical methods was furthermore deemed beneficial in predicting radiation therapy
outcome in a recent head-neck tumor study [21].
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1.3 Diffuse Optical Spectroscopy and Tomography (DOS/DOT)

The DOS/DOT technique often relies on the photon diffusion equation (PDE)
which we make use of to extract tissue absorption information and derive a flow
reconstruction method. The photon diffusion equation is defined with a continuous
wave (𝜔 = 0) source for the photon fluence rate Φ(𝒓) (W/cm2) as [15]:

[∇ ∙ 𝐷(𝒓)∇ − 𝑣𝜇𝑎 (𝒓)]Φ(𝒓) = −𝑣𝑆(𝒓)

(1.1)

with position vector 𝒓 (cm), tissue absorption coefficient 𝜇𝑎 (𝒓) (cm-1), speed of light
in the medium 𝑣 (cm/s), photon diffusion coefficient 𝐷 ≈ 𝑣/3𝜇𝑠′ (𝒓) where 𝜇𝑠′ (𝒓) (cm1)

is the reduced scattering coefficient, and isotropic source term 𝑆(𝒓) (W/cm3).

Unless required for clarity the spatial dependence of the optical properties (𝜇𝑎 , 𝜇𝑠′ )
will not be explicitly noted at every reference. The optical properties also exhibit a
wavelength (𝜆) dependence which will be identified if context demands.
DOS/DOT techniques have been used in the monitoring and imaging of the
reduced scattering coefficient, oxygenated and deoxygenated hemoglobin
concentration, and oxygen saturation in addition to the absorption coefficient [2227]. The absorption coefficient is related to chromophore concentrations as
𝑡ℎ
𝜇𝑎 (𝜆) = ∑𝑚
chromophore’s molar extinction
𝑖=1 𝜖𝑖 (𝜆)[𝐶𝑖 ] where 𝜖𝑖 and [𝐶𝑖 ] are the 𝑖

and concentration, respectively. We do not evaluate chromophore contents in this
study, but the primary biological absorber (wavelength dependent) in most tissues
is hemoglobin with other minor contributors such as water varying in concentration
with tissue type and composition. Using our CW system, we herein monitor
7

changes in the absorption coefficient 𝜇𝑎 (𝒓) (cm-1) only. The extension of the
spectroscopic application to tomography follows the finite element method (FEM)
implementation as described in Chapter 4.

1.4 Diffuse Fluorescence Spectroscopy and Tomography (DFS/DFT)

DFS/DFT establishes a set of coupled equations linking the diffusive
propagation of the excitation light to the diffusive propagation of the
emitted/fluoresced light. This is used to recover sample fluorescence changes and
is commonly applied in cancer research [16, 17, 19, 28-37]. The fluorescence
photon fluence Φ𝑓𝑙 (𝒓) is described by (with CW) [17, 38]:

[∇ ∙ 𝐷𝑒𝑥 (𝒓)∇ − 𝑣𝜇𝑎,𝑒𝑥 (𝒓)]Φ𝑒𝑥 (𝒓) = −𝑣𝑆(𝒓)

(1.2)

[∇ ∙ 𝐷𝑓𝑙 (𝒓)∇ − 𝑣𝜇𝑎,𝑓𝑙 (𝒓)]Φ𝑓𝑙 (𝒓) = −(𝜂𝜖𝑒𝑥 [𝑁])Φ𝑒𝑥 (𝒓)

(1.3)

with excitation and emission parameters subscripted with ex and fl respectively,
the fluorescence quantum yield 𝜂, fluorophore extinction coefficient 𝜖𝑒𝑥 , and the
fluorophore concentration [𝑁]. The absorption coefficients here are contributed to
by both endogenous chromophores and exogenous fluorophores. From Equation
1.3 the RHS can be seen to be the solution to Equation 1.2 modified by the
fluorescence properties and concentration. The fluorescence yield, 𝜂𝜖𝑒𝑥 [𝑁] =
𝜂𝜇𝑎,𝑓𝑙 , is the parameter commonly resolved in practice and its relative change
monitored. If 𝜂 and 𝜖𝑒𝑥 are known, then the absolute concentration can be
separated. In this study, we monitor relative changes in the fluorescent yield as
8

produced by the addition of the exogenous ICG fluorescent agent. Tomography is
implemented within the FEM framework in a manner similar to DOT and is also
described in Chapter 4.

1.5 Diffuse Correlation Spectroscopy and Tomography (DCS/DCT)

DCS/DCT theory is provided by an analogous correlation diffusion equation
(CDE) to the PDE which models the diffusive propagation of the unnormalized
temporal electric field correlation function 𝐺1 (𝒓, 𝜏) = 〈𝐸(𝒓, 𝑡)𝐸 ∗ (𝒓, 𝑡 + 𝜏)〉 in
biological tissues. Fluctuations in this electric field enable detection of the
underlying flow processes and DCS/DCT has been used in many applications
including muscle, brain, and cancer as mentioned earlier [20, 21, 39-62]. The CDE
is defined by [63]:

1

[∇ ∙ 𝐷(𝒓)∇ − 𝑣𝜇𝑎 (𝒓) − 3 𝛼𝑣𝜇𝑠′ (𝒓)𝑘02 〈∆𝑟 2 (𝒓, 𝜏)〉] G1 (𝒓, 𝜏) = −𝑣𝑆(𝒓)

(1.4)

with autocorrelation decay time 𝜏 (s) and wavenumber 𝑘0 . The mean-square
displacement (MSD) 〈∆𝑟 2 (𝒓, 𝜏)〉 describes the motion of scattering particles (e.g.,
primarily moving red blood cells in tissues or Intralipid® emulsions in phantoms) in
time 𝜏. Another factor, 𝛼, accounts for the generally unknown ratio (between 0 and
1) of moving to total scatterers. In practice, we approximate a collimated source as
a diffuse point source one scattering distance into the sample, 1/𝜇𝑠′ [64].
The solution to Equation 1.4 for semi-infinite geometry provides the form of 𝐺1
encountered on media such as the slabs used in experimental phantoms and as
9

an approximation on many real tissues. The corresponding semi-infinite solutions
to Equations 1.1 – 1.3 are of similar form and can be found elsewhere [22, 38].
The semi-infinite solution for 𝐺1 is [65]:

𝑣𝑆

G1 (𝜌, 𝜏) = 4𝜋𝐷0 [

where

2

exp(−𝑟1 𝑀)
𝑟1

𝑀2 = 3𝜇𝑎 𝜇𝑠′ + 𝜇𝑠′ 𝑘02 𝛼〈∆𝑟 2 (𝜏)〉,

√𝜌2 + (𝑧 + 𝑧0 + 2𝑧𝑏 )2,

−

exp(−𝑟2 𝑀)
𝑟2

]

(1.5)

𝑟1 = √𝜌2 + (𝑧 − 𝑧0 )2,

𝑧𝑏 = 2(1 + 𝑅𝑒𝑓𝑓 ) /3𝜇𝑠′ (1 − 𝑅𝑒𝑓𝑓 ),

𝑧0 = 1/𝜇𝑠′ ,

𝑟2 =

𝑅𝑒𝑓𝑓 = −1.440𝑛−2 +

0.710𝑛−1 + 0.0636𝑛 + 0.668 accounts for the refractive index mismatch between
air and the medium, 𝑛 ≈ 1.33 for tissues and tissue-like phantoms, 𝜌 = |𝒓 − 𝒓𝑠 | is
the source-detector (SD) separation with source position 𝒓𝑠 on the sample surface,
and 𝑆0 is the source term. The MSD in tissues is often modeled by Brownian motion
where 〈∆𝑟 2 (𝜏)〉 = 6𝜏𝐷𝐵 with the effective diffusion coefficient of moving scatterers
𝐷𝐵 . The 𝛼𝐷𝐵 term is collectively referred to as the blood flow index, 𝐵𝐹𝐼, which has
been validated against multiple modalities including laser Doppler flowmetry [66,
67], Doppler ultrasound [68, 69], power spectral Doppler ultrasound [60], Xenon
CT [70], arterial-spin-labeled MRI [71], and fluorescent microsphere flow
measurement [72].
A single semi-infinite DCS measurement typically collects the normalized
intensity autocorrelation function, 𝑔2 (𝜌), at a specific SD position 𝜌 by hardware or
software correlator processing of avalanche photodiode (APD) photon counts at
multiple correlation times. This function can be fit to the normalized 𝑔1 (𝜌, 0) of
Equation 1.5 for quantifying 𝛼𝐷𝐵 . The Siegert relationship 𝑔2 (𝜏) = 1 + 𝛽|𝑔1 (𝜏)|2
10

can relate the intensity (measured) and electric field (model) autocorrelation
functions where 𝛽 is subject to the speckle and collection optics [73]. Fitting the
curve for 𝐵𝐹𝐼 and 𝛽 simultaneously has been shown to improve results [74].
Optical fiber selection impact on DCS and other diffuse technologies has also been
reported [75]. We use a novel FEM flow reconstruction method for imaging based
on the PDE implementation, outlined in detail in Chapter 2.

1.6 Current Limitations and Thesis Outline

It is foreseen that a new single imaging instrument divulging both blood flow
and fluorescence distributions in deep tissues is both necessary and desired to
push forward into new potential research investigations. In a recent study, a
relationship between tumor blood flow and nanoparticle deposition according to
liposome size was found [76]. Thus, the 3D imaging of crucial detailed information
about tumor tissue microvasculature and fluorescently-tagged nanoparticle spatial
heterogeneity may significantly enhance realizable treatment efficacy of drug
delivering nanoparticles. That study exemplifies the potential new facets of cancer
research and highlights the difficulties. Imaging was performed with both dynamic
contrast-enhanced computed tomography (DCE-CT) and fluorescence molecular
tomography (FMT) requiring manual co-registration, landmark fiducials, and
carefully interpreting the data acquired separately.
An instrument is thus proposed based on diffuse optical methods with
multimodal flow and fluorescence capabilities. It will perform medical investigations
within the NIR paradigm of diffuse optics, be relatively low cost and portable, have
11

robust sampling density and time, and obviate co-registration and related
complications. Further desirables will include constraints that it be noncontact to
avoid hemodynamic alterations [77-79] and reflectance-mode operation for
translatability across subjects of varying sizes (i.e., small animals to humans). It
would additionally be expandable to measure absorption and related derivatives.
The extension of diffuse optical spectroscopies to tomographic imaging has
brought with it an ascension in multimodal imaging opportunities. Despite
extensive progress, there has been an absence of a device which aggregated all
the proposed features. Specifically, a fully noncontact multimodal diffuse optical
instrument employed in reflectance-mode for the gathering of flow and
fluorescence 3D distributions has yet been missing in the field. The development
of such an instrument is the primary objective of this dissertation. The facilitation
of a fully noncontact system requires moving the source and detection elements
away from the tissue surface. Noncontact DOT/DFT systems have been previously
developed using CCD cameras away from the interface [80-83]. No such systems
have yet combined a reflectance design with CCD-based deep tissue flow imaging.
This absent solution is due in part to the lack in developments of the latter.
Early DCT implementations have relied on the monitoring of light by high
temporal resolution APD’s to establish a correlation curve to fit the theoretical
solution (Equation 1.5) [63, 84-86]. This type of detection element can be
restrictive in its cost, scaling to high density sampling, and physical space
overhead. As an alternative, CCD camera’s offer a cost-effective solution to these
limitations. CCD detection for flow imaging has already been employed abundantly
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in techniques such as laser speckle contrast imaging (LSCI) [87, 88]. In
comparison to our objectives, LSCI methods are largely used to probe superficial
vascular distributions (up to 1 mm depth) with a wide-field illuminated light source
[89, 90]. The extension of speckle contrast to the monitoring and imaging of deep
tissues has been explored by several groups recently and replace the wide-field
illumination with a point-like light source. The approach of diffuse speckle contrast
analysis (DSCA) is to directly monitor inverse speckle contrast variations as a
measure of the proportional change with the DCS 𝐵𝐹𝐼 in the range of typical tissue
properties [91-93]. Speckle contrast optical spectroscopy (SCOS) and tomography
(SCOT) have been developed relating the speckle contrast parameter and DCS
theory [94, 95]. The SCOT imaging uses perturbation and the Born approximation
to establish the sensitivity relationship between changes in flow dynamics directly
to speckle contrast and was tested in the transmission mode.
As mentioned in Chapter 1.5 we have developed a novel flow reconstruction
method. In our approach to CCD-based speckle contrast flow imaging, we retain
our flow reconstruction advantages while deriving a link between it and speckle
contrast flow measurements. This leverages our inherited reconstruction benefits
from DOT developments due to the CDE/PDE equation and solution similarities
while also accomplishing the utilization of a CCD camera for light detection of
speckle contrasts. The speckle contrasts can be converted to boundary 𝐵𝐹𝐼 which
can then be input into the established FEM-based reconstructions and thereby
amalgamate the robustness of CCD detection and previous/future flow imaging
advancements.
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Combining these advances with a noncontact light source and established
DOT/DFT techniques, we expect that the resulting pioneered completely
noncontact CCD-based system will synergize the benefits of all and provide a
powerful new imaging technique for cancer research. In this study we incorporate
the necessary theoretical advancements, hardware and software modifications,
and preliminary testing to instantiate the highly translatable noninvasive imaging
device that will serve as a robust segue between animal and human/clinical
studies. This new technique allows for an accessible multiparameter data set
without the complexities of image coregistration and multiple instrumentation data
acquisition. The potential applications of this new device include the in vivo
characterization of tumor detection and growth by flow distributions and those of
ICG as well as opening the analysis on the relationship between fluorescentlytagged nanoparticles of varied size and localized flow differences.
The chapter outline of this thesis is as follows. The instrumentation is
progressively developed in three stages: noncontact diffuse correlation
tomography (ncDCT), speckle contrast diffuse correlation tomography (scDCT),
and noncontact speckle contrast diffuse correlation tomography and diffuse
fluorescence tomography (nc_scDCT/DFT). Chapter 2 describes the ncDCT flow
imaging instrumentation, complex boundary acquisition, our flow reconstruction
method, and provides the results of a case study of ncDCT application on small
animal tumors. Chapter 3 presents the derived theoretical relationship between
diffuse speckle contrast and the normalized temporal autocorrelation function and
the modified instrumentation for CCD-based detection, termed scDCT, and its
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phantom validation. Chapter 4 follows with the multimodal reflectance-based
nc_scDCT/DFT device prototype and its experimental validation. All personal
contributions are more specifically relayed, along with overall study limitations and
perspectives, in the closing Chapter 5.
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CHAPTER 2 NONCONTACT DIFFUSE CORRELATION TOMOGRAPHY

2.1 Introduction

ncDCT serves as our flow imaging instrumentation progenitor and the
foundational methodology upon which advancements are made in the following
chapters. The novelty of ncDCT can be conceptualized as the straightforward
transition from its stationary predecessor, noncontact diffuse correlation
spectroscopy (ncDCS), to enable noncontact flow imaging. Accomplishing this
goal thereby inherits the benefits of being noncontact and reflectance mode.
ncDCS has been evaluated in simulations, tissue-like phantoms, forearm tissue
cuff occlusions and head and neck cancer free tissue transfer flaps [96-98]. The
ncDCT methods outlined in this chapter have been tested in simulations,
phantoms, and real tissues including human breast tumor [20, 85, 99-101].
In this chapter we begin by examining the ncDCT hardware specifications and
operation. An understanding of this implementation highlights the importance of
our modifications in later chapters. Measuring and incorporating complex
boundaries and finding source and detector surface coordinates is addressed for
completeness. While a necessity in many real tissue encounters, this task is
comparatively negligible in simple phantom models. Next are details of the FEM
flow reconstruction method. This method is utilized throughout the thesis for flow
reconstructions. As it is based on readily available open source software
(NIRFAST, Dartmouth College, NH), seamless integration of geometries and
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inversion algorithm techniques is promoted. The chapter will conclude with the
application of ncDCT to an in-vivo mouse tumor study.

2.2 Instrumentation

A lens-based focusing apparatus suspended from a boom arm orchestrates
the collection of boundary flow measurements (Figure 2.1) [20, 85, 97, 98]. The
apparatus bookends a linear array of 15 single-mode detector fibers (SM800-5.6125, Fibercore, CA) with 2 multimode source fibers (WF200/220/245,
CeramOptec, MA) allowing for a 10 – 30 mm SD range and separate source and
detector paths. The source paths consisted of two lenses (each) to collimate then
focus the source light onto the sample surface. The detector path guided
collimated light onto detector fiber tips after having passed through a 750 nm longpass filter (FEL0750, ThorLabs, NJ) and aperture upon collection by an achromatic
focusing lens. Detector fibers were connected to a bank of avalanche photodiodes
(PerkinElmer, Canada). The APD intensity autocorrelation functions were
simultaneously and dynamically processed by a multiple channel autocorrelator
(Correlator.com, NJ). Each source fiber connected to an 830 nm long coherence
laser (coherence length > 5 m; CrystaLaser, NV). A linear (T-LSM200A, Zaber,
Canada; 5236A16, McMaster-Carr, IL) or rotational (CR1-Z7, Thorlabs, NJ) stager
impressed mechanical translations to scan an ROI with an adjustable step size.
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Figure 2.1: ncDCT instrumentation. The (a) lens-based focusing apparatus is
positioned above a sample and scans over an ROI through mechanical translation
to acquire a set of boundary flow data. (b) Light is projected by two individual
source paths and collected by a linear array of detector fibers. (c) A single scan
step provides SD separations from 10 – 30 mm for each of the two separate
sources.

2.3 Complex Boundary Acquisition and Source/Detector Placement

The FEM reconstruction requires the incorporation of a finite element mesh
representative of the sample and the surface coordinates of source and detector
positions. In the simplest cases we may form a mesh from simple geometries such
as a slab with built-in NIRFAST functionality and use the straightforward SD
projections on a flat surface. In the case of real tissues, we aren’t gifted with such
ideal circumstances and use more involved methods. Contemporaneously with
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ncDCT device development both the surface geometry and SD positioning
concerns were addressed [20, 99].
To acquire the real sample geometry, a photogrammetric scanner (Figure 2.2;
NextEngine, CA) proves a suitable solution. This 3D camera is oriented at an
approximate working distance of 17 inches with a corresponding 10 inch × 13 inch
field of view (FOV). Once stationed, the 3D surface mesh is acquired using the
camera control software (ScanStudio HD, NextEngine, CA) and will include a
reference plane and reference markings which have been manually placed by
marker pen on the subject during ncDCT measurement. The markings generally
correspond to the beginning, middle, and end step source positions for identifying
the ncDCT lens apparatus translations (i.e., the SD arrangement and step length
are static). A solid model is created by extruding a 2D contour (SolidWorks,
Dassault Systemes, MA), where the shape chosen is based on sample similarity
(i.e., circular for breast, rectangular for mouse), starting at the desired depth below
and extending into the surface mesh. The finished solid volume must be of
adequate size to allow diffusive photon propagation without creating a mesh of
substantial processing burdens in reconstructions. From this solid, a 3D mesh was
generated using ANSYS® (ANSYS, PA) with an appropriate average node
distance (i.e., 1 or 2 mm based on previous experiments) and element shape (e.g.,
4-node tetrahedron). In this step, localized mesh refinement (or other advanced
options) can be carried out.
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Figure 2.2: Photogrammetric scanning camera. The 3D camera positioned over
a mannequin exemplifying surface geometry recovery scanning.

In noncontact-based applications the source and detection surface locations
are not always as evident in comparison to contact designs. Mapping the projected
source and detector positions is possible using the volume created by the 3D
camera/extrusion and the source location reference markings. A program written
to advantage the SolidWorks application programming interface (API) determines
the positions in the following fashion. A plane is created perpendicular to the
bottom plane (e.g., used for extrusion) whereby a line is created connecting the
two source positions at an individual step. The program scans chief optical rays
from the line to the sample surface with intersections denoting the proper SD
coordinates. Errors of this method for alignment (< 10% error) were found to be
negligible by simulated recovery of heterogeneity location (0.77 mm deviations <
1 mm node distance) and flow contrast (1% deviation) [99].
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2.4 Flow Reconstruction

The basis of the flow reconstruction procedure resides in the PDE (Equation
1.1) and CDE (Equation 1.4) being analogous, which was the intent of the CDE
[102]. The following Table 2.1 comparison of the equations (P1 approximations;
PDE shown for CW source) and partial-flux boundary conditions (also called Robin
boundary conditions; incoming photon/correlation flux only due to Fresnel
reflections at the interface) illustrates their formal similarity [22, 102, 103]:

Table 2.1: PDE, CDE, and boundary condition comparison
P1 Approximation Diffusion Equations
Photon Diffusion

[∇ ∙ 𝐷(𝒓)∇ − 𝑣𝜇𝑎 (𝒓)]Φ(𝒓) = −𝑣𝑆(𝒓)

Correlation Diffusion

[∇ ∙ 𝐷(𝒓)∇ − 𝑣𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏)]G1 (𝒓, 𝜏) = −𝑣𝑆(𝒓)

Robin Boundary Conditions
Photon Diffusion

𝜕Φ(𝒎)
=0
𝜕𝑛̂
𝜕G1 (𝒎, 𝜏)
G1 (𝒎, 𝜏) + 𝑧𝑏 (𝒎)
=0
𝜕𝑛̂
Φ(𝒎) + 𝑧𝑏 (𝒎)

Correlation Diffusion

where we have replaced the second and third terms in the CDE with a total
absorption
1
3

which

includes

dynamic

processes

as

𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏) = 𝜇𝑎 (𝒓) +

𝛼𝜇𝑠′ (𝒓)𝑘02 〈∆𝑟 2 (𝒓, 𝜏)〉 and that when assuming moving scatterers undergoing

Brownian motion becomes 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏) = 𝜇𝑎 (𝒓) + 2𝜇𝑠′ (𝒓)𝑘02 𝛼𝐷𝐵 (𝒓)𝜏, 𝑛̂ is normal to
the surface, and the boundary conditions specify a boundary position 𝒎. Although
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the notation exhibits spatial variation in both optical properties and 𝐵𝐹𝐼, the flow
reconstruction method to follow attributes all changes to 𝛼𝐷𝐵 (𝒓).
As the analytic solutions for these equations are difficult to achieve except for
simple cases, the problem is described by an FEM formulation which lends itself
well to irregular boundaries and heterogeneous flow. The remaining details in this
section are modified versions for flow (CDE) purposes from previous work done by
others involving the FEM formulation, reconstruction implementations, and
Jacobian calculation by adjoint method as originally outlined for photon fluence
(PDE) and implemented in the NIRFAST (version 9.0) open source software
package [104-107]. In FEM, we make the compromise of knowing the exact
solution everywhere to that of an approximate numerical solution described in
terms of a discrete set of elements and corresponding nodes. The FEM formulation
derives a useful alternative problem formulation which provides the equivalent
(approximate) solution to the CDE while allowing us to adjust the parameter
surrogates. By continuously reducing the element size or increasing the nodal
density, we expect ideally to effectively approach the exact solution for arbitrary
media.
The physical domain Ω is first partitioned into 𝐿 nonoverlapping volume (for our
3D objective) elements 𝐸𝑖 joined at 4 vertex nodes 𝑁𝑖 (for 4-node tetrahedrons)
with 𝐸𝑖 : 𝑖 = 1 … 𝐿, 𝑁𝑖 : 𝑖 = 1 … 4, and the entire region is then constructed from Ω =
∪𝐿𝑖=1 𝐸𝑖 . Also required is an estimate of the continuous physical distribution of the
function of interest (e.g., 𝐺1 ). A piecewise linear polynomial shape function is thus
defined with 𝜓𝑖 (𝑁𝑗 ) = 𝛿𝑖𝑗 = {

1 𝑖=𝑗
, 𝑖, 𝑗 = 1, … , 𝑃 where {𝜓𝑖 }1𝑝 denotes a basis
0 𝑖≠𝑗
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function set with the total number of mesh nodes 𝑃 and has limited support (i.e.,
contributions only from elements sharing node 𝑁𝑖 ). The approximate solution 𝐺1ℎ is
then defined in terms of the basis as 𝐺1ℎ (𝐫, 𝜏) = ∑𝑃𝑖=1 𝐺1,𝑖 (𝜏)𝜓𝑖 (𝒓). There are no
inherent mechanical relationships of significance between the nodes and 𝐺1 and
thus no displacement occurs during analysis. This does not imply external factors
haven’t inadvertently altered the true geometry such as subject movement or
tissue compression during real measurements.
The ability to establish the actual FEM solution is derived in detail for the
analogous PDE elsewhere [64, 104, 105, 107-109]. Briefly, integrations are
performed over each element and the total nodal contributions summed (based on
limited support). The governing equations are given below where 𝜓𝑖 is related to
𝐺1 being expressed in terms of the basis and 𝜓𝑗 is a trial function, resulting in a
(sparse) 𝑃 × 𝑃 “mass” matrix and 𝑃 × 1 source and solution vectors:

[𝑲(𝐷) + 𝑪(𝜇𝑎𝑡𝑜𝑡𝑎𝑙 ) + ζ𝑭]𝐆𝟏 (τ) = 𝑺𝟎

(2.1)

𝐾𝑖𝑗 = ∫Ω 𝐷(𝒓)∇𝜓𝑖 (𝒓) ∙ ∇𝜓𝑗 (𝒓) 𝑑Ω

(2.2)

𝐶𝑖𝑗 = ∫Ω 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓, 𝜏)𝜓𝑖 (𝒓)𝜓𝑗 (𝒓) 𝑑Ω

(2.3)

𝐹𝑖𝑗 = ∫𝜕Ω 𝜓𝑖 (𝒓)𝜓𝑗 (𝒓)𝑑(𝜕Ω)

(2.4)
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𝑆𝑖 = ∫Ω 𝜓𝑖 (𝒓)𝑆0 (𝒓)𝑑Ω

(2.5)

where 𝜁 = 1/2𝐴 is arrived at by applying the Robin boundary condition to a
̂ ∙ 𝑱𝑮𝟏 (𝒎) with normal surface vector
boundary measurement defined by Γ(𝐦) = 𝒏
̂ and correlation flux 𝑱𝑮𝟏 at position 𝒎 [102, 104, 107], and 𝑮𝟏 (𝜏) is the solution
𝒏
vector for nodal 𝐺1 (𝜏). The integrations are evaluated by methods such as
quadrature. The forward solution can be extracted manually or with the versatile
MATLAB® (MathWorks, MA) slash operator for the typical 𝑨𝒙 = 𝒃 equation. Note
that this entire arrangement is used to retrieve results in reference to a single
source application/position.
An inverse problem is required for taking our measured 𝐺1𝑀 boundary data and
finding the flow (technically the total absorption, 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 , is reconstructed)
distribution which produced it. The approach in the modified NIRFAST follows a
Tikhonov minimization with [105]:

2

2

𝐶
𝑡𝑜𝑡𝑎𝑙
𝑀
𝑡𝑜𝑡𝑎𝑙 (𝜏)]
(𝜏) − 𝐺1,𝑖
(𝜏)] + 𝜆 𝑇 ∑𝑃𝑗=1[𝜇𝑎,𝑗
(𝜏) − 𝜇𝑎,0
χ2 = min
{∑𝐵𝑖=1[𝐺1,𝑖
}
𝑡𝑜𝑡𝑎𝑙
μa

(2.6)

with 𝐵 boundary measurements (all valid SD pairs), 𝐺1𝐶 is the forward solution, and
a regularization parameter 𝜆 𝑇 decreases the updated total absorption contribution
each iteration. The resulting update is ultimately given, with the addition of a
Jacobian sensitivity matrix 𝐽, by a Levenberg-Marquardt, 𝛿𝜇𝑎𝑡𝑜𝑡𝑎𝑙 = (𝐽𝑇 𝐽 +
−1

𝜆 𝑇 𝐼) 𝐽𝑇 𝛿𝐺1 with 𝜆 𝑇 ≡ 2𝜆 𝑇 , or Moore-Penrose, 𝛿𝜇𝑎𝑡𝑜𝑡𝑎𝑙 = 𝐽𝑇 (𝐽𝐽𝑇 + 𝜆 𝑇 𝐼)−1 𝛿G1 ,

24

procedure depending on the (secondary mesh) node and boundary measurement
quantities. Further details of this implementation are given analogously for optical
properties in the NIRFAST papers [105, 110]. Iterations are ended after ≤ 2%
projection error between the measured and forward model boundary data. The
reconstructed 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 is then finally used to extract the spatial distribution of 𝛼𝐷𝐵 (𝒓).
We retain the logarithmic transformation on 𝐺1 with the assumption that there is a
large dynamic range of the data [104]. The Jacobian is formed with an adjoint
method as summarized next.
With the analogous (CW) diffusion equations and boundary conditions (Table
2.1), the boundary measurement sensitivity is restated here in terms of 𝐺1 and total
absorptions changes, within the FEM framework and utilizing the reciprocity
relation, as [104, 106, 111]

𝜕[Γ(𝜏)]𝒋
𝑡𝑜𝑡𝑎𝑙
𝜕𝜇𝑎,𝑘

= −𝚿𝐢𝑻 (𝜏)𝑽𝑘 𝑮𝟏,𝒋 (𝜏) = −𝑮𝑻𝟏,𝒋 (𝜏)𝑽𝑘 𝚿𝐢 (𝜏)

(2.7)

where 𝑮𝟏,𝒋 corresponds to the CDE forward solution with 𝒓𝒋 , 𝑉𝑘,𝑖𝑗 (𝜇𝑎𝑡𝑜𝑡𝑎𝑙 ) =
∫Ω 𝜓𝑘 (𝒓𝒋 )𝜓i (𝒓𝒋 )𝜓j (𝒓𝒋 )dΩ is a basis system matrix arising from the expression of
𝑡𝑜𝑡𝑎𝑙
(𝜏)𝜓𝑘 (𝒓𝒋 ), and 𝚿𝐢 is the
the total absorption in basis form 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 (𝒓𝒋 , 𝜏) = ∑𝑃𝑘=1 𝜇𝑎,𝑘
+
solution to the CW adjoint problem [𝐊 + 𝐂 + ζ𝐅]𝚿i = 𝑺+
𝑖 . In this latter problem 𝑆

is a 𝛿-function source of type “Robin” (see Table 2.1 boundary conditions) at the
measurement position 𝒎𝒊 . The source has been tacitly assumed constant with
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respect to changes in 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 . The sensitivity from Equation 2.7 can finally be
applied to form the Jacobian matrix considering all valid SD pairs.
Throughout the description of this flow reconstruction technique we have
largely left the role of correlation time 𝜏 unaddressed. In practice, we select a single
𝜏 leaving the reconstruction procedures nearly identical to the original PDE
implementations. The choice for this parameter, the implications of 𝜇𝑎 and 𝜇𝑠′
contributions to the total absorption, and forward and inverse solution validations
for ncDCT relative flow imaging has been examined in detail elsewhere [85, 112].
It may also be noted that 𝜇𝑎𝑡𝑜𝑡𝑎𝑙 is a function of 𝜏 as is an implicit exp (𝑖

2𝜋𝑐
𝜆

𝜏) on the

CDE source term and should be taken into account in future analyses where the
correlation time is not held constant in reconstructions [103].

2.5 Observations and Limitations

There are several limitations with the ncDCT implementation. Although the
lens apparatus may be scanned along the surface increasing lateral/rotational
density, the linear SD array itself is static. This inhibits transitioning among subjects
and ROI’s of varying sizes and restricts the ability to increase longitudinal SD
density. The SD coverage is improved by mechanical scanning, but this movement
is time consuming (up to 20 minutes). Artifacts due to subject and stager
movements and potential physiological variations from the protracted duration may
be introduced. Further difficulties occur in scaling the design to a greater number
of SD pairs and patterns. Optical fibers and APDs incur inhibitive physical
overhead with increasing number and the associated costs could have diminishing
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returns. Such setups can also become exceedingly complex in accomplishing high
spatial sampling density applications such as tomography. In the scDCT design
we seek to remedy many of these shortcomings. Before moving on to this new
design, a case study with ncDCT on a mouse tumor model is presented.

2.6 Flow Imaging of Mouse Tumors with ncDCT

In this investigation, we examine the flow contrasts between healthy and tumor
tissue in a small animal model with ncDCT. Potential disadvantages of many
current imaging techniques include costs and sensitivity only to morphological
advancements. The microenvironment following rapid tumor growth is marked by
enhanced angiogenesis and metabolic demand [1]. Functional physiological
changes thus may serve as important biomarkers. The abnormal blood flow of
such diseased tissue may provide detectable contrasts with surrounding normal
healthy tissues. Small animal tumor models are employed in device development
due to their availability, ease of control, tumor access, reduced complexity, and
lower cost than human tumors. Imaging applied to small animals can provide a
rapid segue between in-vitro assay-based and in-vivo clinical research and
potentially produce results with fewer animals than traditional methods [28, 29].
Small animals can provide a faster and more cost-effective mechanism for
evaluating criteria of potential concepts prior to a clinical trial. Combining the
ncDCT technique with a mouse mammary tumor model allows visualization of
tumor region blood flow contrasts with surrounding healthy tissues.
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2.6.1 Tumor Model

Human breast cancers commonly overexpress the ErbB-2 gene and breast
cancer patients with high ErbB-2 have poor prognosis [113-115]. It has been found
that ErbB-2 overexpression promotes hypersensitivity to ethanol [116].
Furthermore, ethanol has been found to encourage tumor growth and
angiogenesis [117]. Due to its ethanol response, aggressive MDA-MB231 breast
cancer cells may be investigated [117]. In the current case study, we employ
ncDCT in measuring the blood flow characteristics of an athymic nude (NU/NU)
mouse (Harlan Laboratories, IN) dorsally inoculated with aggressive MDA-MB231
breast cancer cells (2 × 106 cells per each of two sites). The tumors were allowed
to grow until palpable and one had reached at least 5 mm in diameter to promote
high flow contrasts. Measurements were then acquired by ncDCT on two separate
days denoted as Day 1 and Day 4. Mice were euthanized following the last
measurement. All procedures were carried out according to the guidelines for the
care and use of laboratory animals implemented by the National Institutes of
Health and the Guidelines of the Animal Welfare Act approved by the Institutional
Animal Care and Use Committee of the University of Kentucky.

2.6.2 Data Collection

Each measurement consisted of the following protocol. The mouse was first
anesthetized through intraperitoneal injection. The animal was secured into
position with its ventral side on a platform. The platform (excluding the mouse) was

28

covered to help minimize ambient light contributions. The ncDCT device as
outlined in Chapter 2.2 is arranged longitudinally with the one laser source
projected near the neck and the other the tail as shown in Figure 2.3. Data is
collected at 16 steps as the lens apparatus is mechanically scanned in 1.0 mm
increments transverse to the head-tail orientation. At each step data was acquired
at 0.5 Hz sampling with 15 s collection for each source, alternately. This data was
fit using Equation 1.5 and the Siegert relation for a complete set of boundary 𝐵𝐹𝐼.
The actual source positions were marked on the animal after the first and last step
for SD coordinate calculations.

Figure 2.3: ncDCT mouse tumor data acquisition. Illustration of the mouse
orientation with respect to ROI, noncontact probe alignment, and scan direction.
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Following ncDCT, photogrammetric scanning of the mouse curvature was
taken, and a mesh was then created. The mesh was combined with the boundary
data and calculated SD positions for flow reconstruction. The corresponding mesh
of bounding dimensions (mm) [Day 1: 45.6 (H) × 21.4 (W) × 24 (D); Day 4: 46.7
(H) × 18.4 (W) × 22.4 (D)] with nodes [Day 1: 25,610; Day 4: 20,885] of average
1.00 mm node distance is shown in Figure 2.4 for both days with visualized SD
locations. These complex boundary and mesh steps followed the methods
described in Chapter 2.3. Of the total SD combinations, only pairs which coincide
with each step of the linear apparatus positioning are valid resulting in 480
boundary measurements (2 sources × 15 detectors × 16 steps). A secondary pixel
basis mesh of [25 25 25], single delay time of 𝜏 = 3.2 × 10−6 𝑠 [85], and optical
properties of 𝜇𝑎 = 0.03 𝑚𝑚−1 , 𝜇𝑠′ = 1 𝑚𝑚−1 were used in reconstructions.

Figure 2.4: Coverage of source and detector locations on the mouse. The
source (red spheres) and detector (yellow spheres) locations are shown for the (a)
first day and (b) fourth day.
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2.6.3 Results

A region of known healthy tissue was used for normalization to produce tumorhealthy relative blood flow [𝑟𝐵𝐹 = (𝛼𝐷𝐵 /𝛼𝐷𝐵,0 ) × 100%; 𝛼𝐷𝐵,0 from healthy region]
contrasts. From the tomographic reconstructions, a threshold of two standard
deviations above the mean was used to separate the abnormal/tumor tissue flow
from that of healthy tissues. Visual inspection supplemented the quantitative
segmentation by manually categorizing regions as that of the large tumor, small
tumor, or artifacts based on the known tumor palpations. In agreement with
expectations, segmented regions were primarily limited to regions of tumor growth
for both days as evidenced in Figure 2.5. There are two uniquely identifiable
tumors on both occasions.
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Figure 2.5: ncDCT mouse tumor reconstruction. The segmented 3-D tumor
relative blood flow (rBF) contrasts for (a) day 1 and (b) day 4 are shown.
Perspectives normal to the XZ and YZ plane are also shown (right).

The tumor volumes (𝑉) and average relative tumor-healthy blood flows (𝑟𝐵𝐹)
were quantified using the segmented and separated tumor data and listed in Table
2.2. The tumor volumes both increased over the four days duration with an
observed ~1.75- and ~3-fold change in the large and small tumors, respectively.
The tumor blood flow averages exhibited a discrepancy between the large and
small tumors. The smaller increased 25% while the larger decreased 10%.
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Table 2.2: Recovered mouse tumor characteristics
Large Tumor

Small Tumor

𝑽 (mm3)

𝒓𝑩𝑭

𝑽 (mm3)

𝒓𝑩𝑭

Day 1

155.82

1.78 ± 0.78

11.82

1.20 ± 0.09

Day 4

276.40

1.60 ± 0.70

34.84

1.50 ± 0.42

2.6.4 Observations and Limitations

The trend in tumor volumes from Table 2.2 for both tumors coincides with
uncontrolled tumor growth. Further elevations in tumor volumes is anticipated to
be minimal due to practical circumstances. Specifically, the tumors can begin to
present with open wounds and the mouse subject will experience discomfort soon
after the sizes observed. The varied average tumor blood flow is reasonable as
the inside of solid tumors can develop poor circulation and even necrotic regions
due to lack of nutrients and inadequate vessel structures. The resolution of ncDCT
may not easily discern such regions until they grow to mm sizes but is still
influenced by the partial volume effects on the boundary measurements. The
average tumor flow contrast with healthy human breast tissues as measured by
DCS and ncDCT in vivo have been reported between 2- to 10-fold [20, 58, 59].
The average flow contrast measured herein is just under this range. Some
discrepancies due to partial volume effects, breast tumors in a mouse model, and
lack of optical property information will contribute to inaccuracies in flow
estimations [112, 118]. Overall, the application of the ncDCT technique to imaging
small animal (mouse) mammary tumor blood flow contrasts was supported by this
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case study. The regions of tumor tissues were identified and found localized
proximal to their true locations. Average blood flow distributions were
characterized with positive success in agreement with literature.
There are areas where this study was limited and future optimizations which
are both possible and necessary. The detection area being distributed across the
entire animal is undesirable due to some asymmetry of internals (e.g., liver), large
heterogeneity in tissue types and optical properties, large separation of SD
combinations (i.e., SD sensitivity is typically half the separation distance), and laser
source projections near the edges such as the neck and tail area. These
deficiencies are predominantly due to the development of the ncDCT lens
apparatus for human scale ROI’s. The mouse body is several centimeters in length
and pushes the lens focusing apparatus to the margins of its applicability. Future
studies should narrow the ROI to a smaller region of tissue and SD separations
which limit penetration and optimize sensitivity. In proceeding chapters, instrument
design allows for this robust translational potential.
Measurement of the tissue optical properties can be accomplished through
addition of DOS/DOT techniques to attempt further improvements in blood flow
estimates. The absorption and reduced scattering coefficients used coincided with
literature, but there is a large variation across tissue types [119-122].
The scan time, also addressed in proceeding chapters, is another undesirable
system trait. The animal though secured and anesthetized has intermittent
exaggerated respirations and twitches which can introduce artifacts over the scan
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period of ~8 minutes. Reducing the data collection duration will help reduce the
impact of these occurrences.
The modest boundary curvature makes suspect that there is consistent
modeling with the semi-infinite solution (Equation 1.5). Monte Carlo (MC)
modeling may improve the recovered data and understanding of the curvature and
angle of incidence influences. A previous study noted curvature influence on
absolute 𝛼𝐷𝐵 with a negligible affect on 𝑟𝐵𝐹 [98]. Such analysis uses the form of
𝑔1 explicitly including the path length distribution as obtainable from MC
simulations. In future mouse studies an assumption of negligibility should be
assumed invalid and require case-specific analysis. This is due to the spatial
heterogeneity of curvature which will also change over time with a palpable tumor.
The progression of size in the smaller tumor as seen in Figure 2.5 is thus expected
to supply less reliable results. Additionally, the separation for a particular SD pair
as defined for the semi-infinite solution uses a flat boundary, but has ambiguous
meaning (e.g., shortest direct distance or geodesic distance) and inaccurate
applicability with regard to a curved boundary. Alternatively, limiting the ROI to a
smaller area can reduce these effects with a sufficiently modified lens apparatus
as mentioned above. A technique developed specifically for extracting DCS flow
indices on complex curvatures has recently been developed and may be
incorporated in future studies for flow boundary data reconciliation [123, 124].
Several other improvements may also be incorporated into future related
studies. Further flow progression information can be made available by extending
the longitudinal monitoring to earlier time points including early tumor growth. To
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support the findings shown, validation should be performed against other
modalities and/or techniques such as CD34/microvessel density after tumor
excision. Lastly, a heating element is needed to assist in maintaining the animal
body temperature and preventing flow changes throughout the measurement
duration.
An uncertainty arose after the measurements were concluded concerning the
source fiber attachments to the lens focusing apparatus. The source orientation
(i.e., source 1 top/source 2 bottom or source 1 bottom/source 2 top) was
determined by comparing usage of the ncDCT device in experiments near the
relevant dates and the results for the 2 separate mouse measurement days.
Several other mice were measured, but due to insufficient data for longitudinal/selfcomparison and compounding complications in assumptions from the uncertainty
above they were excluded from analysis.
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CHAPTER 3 SPECKLE CONTRAST DIFFUSE CORRELATION
TOMOGRAPHY

3.1 Introduction
In this chapter we proceed from APD’s to CCD detection and develop the
background for moving between speckle contrast flow measurements and our flow
reconstruction technique while describing the system built for exemplification. As
this method transitions raw flow measurements from intensity correlation to
speckle contrast we term it speckle contrast DCT (scDCT). This unique system
facilitates CCD-based 3D flow contrast imaging of complex turbid media. We first
look at the scDCT instrumentation and how it is oriented for taking data in an
experimental setup. Following this is the derivation of the speckle contrast flow
detection in semi-infinite media which enables utilizing the CCD camera as
opposed to APD’s. We continue with the image pre-processing details including
noise corrections and a smear correction algorithm. Finally, we apply this scDCT
technique on reflectance-based measurements of tissue-like phantoms. The
derivation [100] and system and experimentation [125] described herein have been
published. A low cost compact spectroscopic alternative has also been proposed
[126].

3.2 Instrumentation and Experimental Setup

In scDCT we replace the APD detection elements of ncDCT by a single highly
sensitive electron-multiplying CCD (EMCCD; Cascade 1K, Photometrics, AZ). This
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method of detection allows for many (e.g., up to ~1 million [1004 x 1002 pixels];
camera dependent) effective detector measurements due to the populated pixel
grid. It also removes the scanning overhead and time penalty of the ncDCT design.
The camera specifications are shown in Table 3.1. The maximum full frame rate
achievable is ~9 frames per second (fps; we average ~8 fps in practice) without
binning (up to ~33 fps with binning at the expense of resolution; no binning is used
in the current investigation). The quantum efficiency of the camera is shown in
Figure 3.1. The 785 nm long-coherence laser (coherence length > 5 m;
CrystaLaser, NV) used coincides with a quantum efficiency slightly under 45%
from the referenced figure. The camera backing is mounted to a heavy base
seated upon a mobile cart which can be quickly moved between laboratory settings
and clinical rooms. The reflectance mode orientation more adequately represents
the situation encountered in larger subjects such as humans where transmission
is not practical in most cases (due to the limited penetration depth of light),
enhancing translatability to different ROI’s and subjects (e.g., small animals).

Table 3.1: Cascade 1K EMCCD specifications
Specification

Details

Format

1004 pixels x 1002 pixels; 8 µm x 8 µm pixels

Linear full well single pixel

30,000e-

Digitizer

16 bits @ 10 MHz

Frame readout

110 ms/frame; 1 ms (image-to-storage shift time)
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Figure 3.1: Quantum efficiency of the Cascade 1K EMCCD. The quantum
efficiency corresponding to the 785 nm laser source is denoted by a dashed red
line.

A zoom lens (Zoom 7000, Navitar, NY) is attached to the CCD camera opening
as shown in Figure 3.2a. The lens is aligned concentrically to the FOV over a liquid
phantom surface (Figure 3.2b). The zoom lens was set with a 35 mm focal length
and F-number of 8 to make the focal plane agree with a tissue-like liquid phantom
surface and to satisfy the speckle size Nyquist sampling criteria [127], respectively.
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Figure 3.2: CCD camera and experimental setup. (a) The EMCCD is focused
by zoom lens onto a liquid phantom surface. A square metal holder positioned the
ferrule tips of four optical fibers on the liquid surface. The holder provided a 2.4 cm
× 2.4 cm open area. The optical switch distributed laser light into the four source
fibers sequentially. (b) Configuration of the four sources, CCD, FOV, solid phantom
placement, and detector area.
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A blocking fiber optic switch (VX500, DiCon, CA) was custom designed with
two-channel inputs and four-channel outputs. Here we use it to deliver photons
from a single laser input to four multimode optical fibers (FT200UMT, Thorlabs,
NJ; 200 µm core fiber with 0.39 NA and FC/PC connector) individually (see
Figures 3.2a and 3.3). The 2 × 4 switching mechanism is reversible and can allow
low-loss light throughput in the opposite direction in future applications. The switch
is optimized for wavelengths in the range of 600 – 860 nm. The switch output fibers
(S1 to S4 in Figure 3.2b) were led to a metal holder with a 2.4 cm × 2.4 cm open
center with their ferrule tips held in place symmetrically around the FOV perimeter.
The effective positions were located 1.5 cm from the FOV edge centers. A
LabVIEW ® (National Instruments, TX) program was written to control the optical
switch operation through an A/D board.

Figure 3.3: The blocking and switching mechanism of the optical switch. The
785 nm laser light was connected to input 1 and sequenced from output 1 through
4. The blocking feature restricts input 2 light from passing through any output
channel when only input 1 light passage is desired (or conversely). No light source
is connected to input 2 in the current investigation.
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3.3 Speckle Contrast

To facilitate determination of blood flow indices by CCD detection we borrow a
concept from LSCI termed speckle contrast. In typical LSCI a wide-field light
source is applied across a region for monitoring superficial flow variations by
quantifying the speckle contrast in a local region as [87]:

𝜎

𝐾𝑠 (𝒓) = 〈𝐼〉𝑠

(3.1)

where 𝜎𝑠 is the spatial (or temporal) standard deviation and 〈𝐼〉 is the mean intensity
of a set of pixels (e.g., a window). We seek to extend this into speckle patterns
created by photons having traversed diffusely up to a few centimeters depth within
biological tissues. We thus turn to the following relationship (assumes the Siegert
relation) between the speckle contrast parameter and 𝑔1 :

𝐾𝑠2 (𝒓) =

2𝛽
𝑇

𝑇

𝜏

∫0 (1 − 𝑇) 𝑔12 (𝒓, 𝜏) 𝑑𝜏

(3.2)

where 𝑇 is the exposure time and 𝛽 relates the detector and speckle sizes [128].
Using the normalized semi-infinite analytic solution 𝑔1 (𝒓, 𝜏) = 𝐺1 (𝒓, 𝜏)/𝐺1 (𝒓, 0)
from Equation 1.5 and rewriting we obtain

𝑔1 (𝒓, 𝜏) = 𝐶[𝑟2 exp(−𝑟1 𝑀) − 𝑟1 exp(−𝑟2 𝑀)]
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(3.3)

−1

where 𝐶 = [𝑟2 exp(−𝑟1 √3𝜇𝑎 𝜇𝑠′ ) − 𝑟1 exp(−𝑟2 √3𝜇𝑎 𝜇𝑠′ )] . Inserting Equation 3.3
into Equation 3.2,

𝐾𝑠2 (𝒓) =

𝑟12 exp(−2𝑟2 𝑀)
𝑇
∫0 {−2𝑟1 𝑟2 exp(−[𝑟1 + 𝑟2 ]𝑀)} 𝑑𝜏
2
+𝑟22 exp(−2𝑟1 𝑀)
2𝛽𝐶
𝑇
𝑟12 exp(−2𝑟2 𝑀)
1 𝑇
− 𝑇 ∫0 𝜏 {−2𝑟1 𝑟2 exp(−[𝑟1 + 𝑟2 ]𝑀)} 𝑑𝜏
+𝑟22 exp(−2𝑟1 𝑀)
[
]

(3.4)

which can be rewritten in terms of 𝑀 as

𝜏=

𝑀2 −3𝜇𝑎 𝜇𝑠′
2

6𝜇𝑠′ 𝑘02 𝛼𝐷𝐵

(3.5)

and

𝑑𝜏 =

𝑀
2
3𝜇𝑠′ 𝑘02 𝛼𝐷𝐵

𝑑𝑀.

(3.6)

We can consider the integrals of the following two general forms with their
corresponding solutions

𝐴=

=

1
2

3𝜇𝑠′ 𝑘02 𝛼𝐷𝐵

1
2
3𝜇𝑠′ 𝑘02 𝛼𝐷𝐵

𝑏

∑3𝑖=1 𝑥𝑖 ∫𝑎 𝑀 exp(𝑦𝑖 𝑀) 𝑑𝑀

𝑥

∑3𝑖=1 ( 2𝑖 ) [(𝑦𝑖 𝑏 − 1) exp(𝑦𝑖 𝑏) − (𝑦𝑖 𝑎 − 1) exp(𝑦𝑖 𝑎)]
𝑦
𝑖
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(3.7)

and

𝑏

3

1
𝐵=
∑ 𝑥𝑖 ∫(𝑀2 − 3𝜇𝑎 𝜇𝑠′ )𝑀 exp(𝑦𝑖 𝑀) 𝑑𝑀
4 4
′
18𝜇𝑠 𝑘0 (𝛼𝐷𝐵 )2
𝑖=1

𝑎

𝑦𝑖 3 𝑏 3 − 3𝑦𝑖 2 𝑏 2 − 𝑦𝑖 3 𝑏𝑎2
(
) exp(𝑦𝑖 𝑏)
1
𝑥𝑖
3
2 2
∑
=
(
)
[
]
+6𝑦
𝑏
+
𝑦
𝑎
−
6
4
𝑖
𝑖
4
𝑖=1
𝑦𝑖
18𝜇𝑠′ 𝑘04 (𝛼𝐷𝐵 )2
2 2
+2(𝑦𝑖 𝑎 − 3𝑦𝑖 𝑎 + 3) exp(𝑦𝑖 𝑎)

with

𝑟12
𝑥𝑖 = {−2𝑟1 𝑟2
𝑟22

𝑖=1
𝑖=2
𝑖=3

,

−2𝑟2
𝑖=1
𝑦𝑖 = {−(𝑟1 + 𝑟2 ) 𝑖 = 2,
−2𝑟1
𝑖=3

𝑎 = √3𝜇𝑎 𝜇𝑠′

(3.8)

and

𝑏=

√6𝜇𝑠′ 2 𝑘02 𝛼𝐷𝐵 𝑇 + 3𝜇𝑎 𝜇𝑠′ . The final solution is then

𝐾𝑠2 (𝒓) =

2𝛽𝐶 2
𝑇

1

[𝐴 − 𝑇 𝐵]

(3.9)

The theoretical diffuse speckle contrast can be seen to be a function of several
parameters, explicitly 𝐾𝑠2 (𝒓) = 𝑓(𝛼𝐷𝐵 , 𝑇, 𝜇𝑎 , 𝜇𝑠′ , 𝜆, 𝛽, 𝑘0 , 𝒓). We assume that all
parameters remain constant throughout the camera integration time. All
parameters are known, measurable, or estimated from literature except for 𝛼𝐷𝐵
(i.e., the blood flow index, 𝐵𝐹𝐼). The relationship between the diffuse speckle
contrast, SD separation, and exposure time 𝑇 is nonlinear as shown in Figure 3.4.
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Figure 3.4: Variation in diffuse speckle contrast. Variations in speckle contrast
are shown over a typical range of SD separations and exposure times 𝑇.

Extraction of the 𝐵𝐹𝐼 for each SD pair is carried out as follows. The
experimentally measured diffuse speckle contrast is calculated from CCD camera
measurements by Equation 3.1 with noise corrections, which we term 𝐾𝑠𝑒 for
illustrative purposes. The theoretical diffuse speckle contrast is calculated by
2
Equation 3.9, similarly termed 𝐾𝑠𝑡
. As 𝐵𝐹𝐼 is unknown, we finally minimize the
2
2 )2
squared difference between the two speckle contrasts, min(𝐾𝑠𝑒
− 𝐾𝑠𝑡
, with
𝛼𝐷𝐵

respect to 𝐵𝐹𝐼.
The 𝐵𝐹𝐼 obtained from this speckle contrast method by CCD detection is
considered equivalent to that obtained from APDs and Equation 1.5. As such,
reconstructing flow distributions is performed as described in Chapter 2 with the
difference only existing in the acquisition of the boundary 𝐵𝐹𝐼 data.
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3.4 Image Pre-Processing and Reconstruction

Prior to applying speckle contrast-based flow recovery, the raw images were
preprocessed to account for several negative factors including smear and noise
contributions. The speckle contrast obtained from a frame transfer EMCCD
camera may deviate from the theoretical value due to intensity disorder originating
from the frame transfer process [129]. More specifically, visual stripes (smears)
are induced extending from bright features in the image into the direction opposite
that of the charge transfer process. Along this direction, the smear can be
corrected using an algorithm described by Equation 3.10. The actual pixel
intensity signal of the 𝑥th column and 𝑦th row, 𝑖(𝑥, 𝑦), can be restored by the
measured value 𝑖 ′ (𝑥, 𝑦) with

𝑖(𝑥, 𝑦) = 𝑖 ′ (𝑥, 𝑦) −

𝜂𝑓𝑡 𝑡𝑓𝑡
𝑛𝑝 𝑇

∑𝑦−1
𝑛=1 𝑖(𝑥, 𝑛)

(3.10)

where 𝑡𝑓𝑡 is frame transfer time, 𝑛𝑝 is number of pixel rows when the frame has
moved to the readout buffer, and 𝜂𝑓𝑡 is the efficiency with which photoelectrons
are generated during the charge-transfer process relative to the efficiency with
which photoelectrons are generated during the image capture period. Our EMCCD
frame transfer time is ~1 ms. We set 7 × 7 windows at the same distance to the
source location for a symmetric intensity distribution, leading to 𝜂𝑓𝑡 value of 0.67.
Speckle contrast contributions due to hardware noise (i.e., shot noise and dark
noise) are accounted for correcting the speckle contrast computation (Equation
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3.1) of windowed regions [94, 130]. Details of these corrections can be found
elsewhere [94]. Briefly, dark images are used to mitigate speckle contrast
influences from dark noise, 𝐼𝑐 = 𝐼 − 𝐼𝐷 , where 𝐼 is the original intensity of a single
pixel and 𝐼𝐷 is the intensity of dark current. The shot noise of 𝐼𝐶 follows Poisson
statistics, 𝜎𝑠 (𝐼𝐶 ) = √𝜇(𝐼𝐶 ), which are incorporated into the correction calculation.
The shot and dark corrected speckle contrast is then given by

𝜎2 (𝐼)−𝜎2 (𝐼𝐷 )−𝜎𝑆2 (𝐼𝐶 )
.
𝜇 2 (𝐼𝐶 )

𝐾=√

(3.11)

The tomographic reconstruction process is the same as described in Chapter
2 with the boundary 𝐵𝐹𝐼 now provided as described in Chapter 3.3 and above. A
single delay time of 𝜏 = 3.2 × 10−6 𝑠 was used [85]. The SD separation is
determined for each effective detector as the center of the region covered by its
associated pixels.

3.5 Experimental Protocol

Two types of tissue-like phantoms were incorporated for experimentation. The
background consisted of a liquid phantom mixture comprised of distilled water,
India ink (Black India 44201, Higgins, MA), and Intralipid (Fresenius Kabi,
Sweden). This phantom maintained an effectively homogeneous set of optical
properties comparable to real tissues as 𝜇𝑎 = 0.05 𝑐𝑚−1 and 𝜇𝑠′ = 7.0 𝑐𝑚−1 and
flow from Intralipid particle Brownian motion as 𝐷𝐵 ≅ 1 × 10−8 𝑐𝑚2 /𝑠 (assumed
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[118]). In our homogeneous liquid phantom experimentation all scatterers are
dynamic (𝛼 = 1) and we thus write 𝐷𝐵 . For satisfying the need for flow contrast, a
7 mm side length cube-shaped solid phantom was created of carbon black (Alfa
Aesar, IL), titanium dioxide (Alfa Aesar, IL), and silicone (Circuit Specialists Inc,
AZ) [112]. Its associated properties supplied 𝐷𝐵 about three orders of magnitude
lower than the liquid phantom background while matching optical properties (𝜇𝑎 =
0.05 𝑐𝑚−1, 𝜇𝑠′ = 7.0 𝑐𝑚−1 ). The cube was submerged at 2 mm depth beneath the
surface in the FOV center.
The scDCT speckle contrast measurement protocol was identical for both the
presence and absence of the solid cube in the liquid phantom background and was
as follows. A source position was first selected with the optical switch. The CCD
camera then acquired 30 frames at a frame rate of 8 fps while set at 2 ms exposure
time. Collection of raw images was repeated in this manner for the remaining three
source positions. A set of 9 × 9 detectors were defined and centered in the FOV
over 1.0 cm × 1.0 cm (Figure 3.2b) surrounding the cubical target (when
applicable). With the static source and defined detector positions, SD separations
ranged from 1.0 to 2.0 cm with 1.25 mm detector separation distance. Each
detector (0.42 mm × 0.42 mm) was comprised of 3 × 3 windows which in turn
contained 7 × 7 pixels (8 μm pixel size). For each preprocessed image, the speckle
contrast was calculated per window and subsequently averaged across all
windows corresponding to their associated detector. Localized speckle contrast
averages were then calculated along obtained frames for all sources.
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Prior to heterogeneity inclusion, the homogeneous phantom was measured
with scDCT and DCS for calibration purposes. Practically, the optical constant 𝛽
for CCD is not available for measurement. Therefore, a DCS instrumentation was
utilized with an APD-connected single-mode detection fiber (𝛽 = 0.5) to measure
𝐵𝐹𝐼 as calculated by Equation 1.5 and thus serving as the standard. This 𝐵𝐹𝐼 was
used with Equation 3.9 providing the expected speckle contrast with unknown 𝛽
(for CCD). As the sample was homogeneous with respect to the optical properties
and 𝐵𝐹𝐼 this enabled the determination of appropriate calibration factors at all SD
separations.

3.6 Smear Correction Improvements and Speckle Contrast Flow Validation

The influences of smear correction are considered first. Figure 3.5a illustrates
the intensity distribution with source S2 on the homogeneous phantom. The bias
of intensity is evident in the direction of frame transfer (towards S2). Figure 3.5b
shows the distribution after desmearing, demonstrating a normal presentation for
point source intensity. To quantify the desmearing influence we consider an array
of detectors defined along the center row in line with the source location as shown
relative to S2 in Figure 3.5a. The number of effective detectors is increased to 21
along this line (see the ROI and dots in Figure 3.5a) for enhanced illustration of
the smear influence. The detectors are otherwise defined as outlined previously.
The SD ranges from 1.0 to 2.0 cm. Each remaining source is processed to examine
smear correction influence similarly, but with different center row orientation based
on source location. The measured 𝐾 for such detectors and each source with and
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without desmearing is shown in Figure 3.6a, along with the calculated 𝐾. It can be
seen that the desmeared 𝐾 correlates with the calculation. The region of usable
speckle contrast without desmearing is obviously limited with S2 most noticeably
impacted. This is due to our system configuration in which frame transfer occurs
in the direction from S4 to S2.
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Figure 3.5: Effect of smear correction on image intensity. (a) Original intensity
pattern for source S2 on the homogeneous phantom. (b) Desmeared intensity
distribution of (a) with a corresponding SD separation axis. These images depict
contours of the intensity profiles with dots representing 21 effective detectors for
demonstrating the 𝐾 distribution with the SD separations. Note that the dots are
not to scale and the smaller dots serve as an ellipsis for the intermediate detectors.
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Figure 3.6: Speckle contrast 𝐾 and 𝐷𝐵 influences from smear. (a) 𝐾 for all
sources from detectors defined along the center row with and without smear
correction (SC) and numerically simulated 𝐾 at the SD separations. (b) 𝐷𝐵 for
center row detectors.
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After smear correction we can compare the flow indices measured by the new
EMCCD speckle contrast method and standard DCS. Continuing from the previous
analysis, the 𝐷𝐵 value across the center row of detectors is shown in Figure 3.6b.
The 𝐷𝐵 values achieved from DCS at 2.0 cm SD separation and those
independently averaged for S1 to S4 at the 21 detectors are shown in Table 3.2.
The CCD measured 𝐷𝐵 are in good agreement (within 12%) with the standard DCS
measurement. The comparison of 𝐾 distributions measured from S1 on the
homogeneous and heterogeneous phantoms is shown in Figure 3.7.

Table 3.2: Average DB from EMCCD and DCS
Source

Average 𝑫𝑩 (× 𝟏𝟎−𝟖 𝒄𝒎𝟐 /𝒔)

EMCCD – S1

1.19 ± 0.05

EMCCD – S2

1.18 ± 0.08

EMCCD – S3

1.17 ± 0.06

EMCCD – S4

1.13 ± 0.06

DCS @ 2.0 cm SD

1.28
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Figure 3.7: Measured speckle contrast distributions on homogeneous and
heterogeneous phantoms.

3.7 Flow Heterogeneity Detection and Characterization

To examine the performance of scDCT in detecting and characterizing flow
contrast, we next measure the liquid phantom with the submerged solid cube
heterogeneity (Figure 3.2b). Boundary 𝐵𝐹𝐼’s were acquired from measured
speckle contrast, using Equations 3.1 and 3.9, and combined with those obtained
from the homogeneous phantom for relative changes. The boundary flow
information and valid SD pairs were integrated with the following mesh for image
reconstructions. A finite element mesh [dimension (mm): 60 (H) × 60 (W) × 30 (D)]
centered at (0, 0, 15) with an average 3 mm node distance, 4-node tetrahedrons,
and optical properties matching the phantoms provided a slab-shaped
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representative geometry. The mesh was refined in the region known to contain the
heterogeneity to improve detection resolution while not overwhelmingly increasing
the number of nodes. Refinement was within a 15 mm radius (e.g., inclusive of 5
elements) centered from (0, 0, 30) to a 1.5 mm node distance (total nodes: 10,307)
using ANSYS. The relative blood flow, 𝑟𝐵𝐹, is used to denote the ratio of phantom
with heterogeneity to homogeneous phantom 𝛼𝐷𝐵 ’s. The reconstructed image
from homogeneous phantom and heterogeneous phantom are shown in Figures
3.8a – 3.8b. A reconstructed heterogeneity was clearly recognizable from the
overlaid cross-sections compared between the two images. Figure 3.8c shows
cross-sectional views of the heterogeneity extracted by half max contrast threshold
criteria. The averaged heterogeneity 𝑟𝐵𝐹 was 0.38 with center (-0.0, -0.1, 25.0)
close to the actual center (0, 0, 24.5). Reconstructed heterogeneity side length
was 7.2 mm with dimensions that were accurate compared to the true solid
phantom.
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Figure 3.8: Reconstructed 3D flow contrasts. Two-dimensional cross-sectional
view (x and y through side centers; z at 24.5) of slab phantom (a) without
heterogeneity and (b) with heterogeneity. (c) The region with heterogeneity as
extracted by half max contrast threshold criteria. The true region with heterogeneity
is depicted by centered squares. (d) The extracted (half max contrast threshold)
region with heterogeneity obtained by computer simulation.
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For comparison with the ideal scenario, we simulated the phantom experiment
by computer using identical parameters. The region with heterogeneity extracted
by half max contrast threshold is shown in Figure 3.8d. The reconstructed
heterogeneity averaged 𝑟𝐵𝐹 was 0.37 with center (-0.1, 0.0, 24.0), similar to
phantom results (averaged 𝑟𝐵𝐹 within 3% of phantom test results). Corresponding
3D flow distributions were also similar to the phantom experiment (Figure 3.8b)
and hence not shown. In order to examine the effect of centering the heterogeneity
symmetrically in the FOV, we also performed two simulations with it placed in offcenter locations, but in an otherwise matching setup. The reconstructed center and
side length were both in agreement with expectations.

3.8 Observations and Limitations

In this study, an exposure time of 2 ms was selected to achieve a good contrast
to noise ratio [131]. Inherent in this selection was an adverse smear effect. This
was resolved by post data collection analysis, but other solutions exist such as
shutters or laser gating. The reconstruction and boundary data parameters of delay
time 𝜏 and window size used herein have been discussed elsewhere [88, 132]. We
acknowledge that static scatterer contributions can degrade the current model.
Ideally, recovered 𝑟𝐵𝐹 would be zero. However, we only sought to validate 3D flow
contrast detection using our new scDCT method rather than optimize flow recovery
accuracy, and we produced sufficient contrast to identify and characterize the
anomalous presence. The agreement between scDCT and DCS on a
homogeneous phantom and between simulation and phantom in heterogeneity
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detection supports success. Furthermore, multiple two-dimensional SD pairs
provided by the CCD omits the probe scanning in ncDCT, and thus significantly
improves the spatial and temporal resolution. In addition, due to decreasing signal
with increased SD separation using a point source we were limited to at most 2.2
cm after noise correction. Nevertheless, this SD separation is still capable of
probing tissues ~1 cm depth.
We also note that although the FEM framework allows incorporating complex
heterogeneities and boundaries we chose to exemplify our technique in a
straightforward setup. Further difficulties may be encountered when extending
scDCT to real complex media. For example, surface curvature may result in
modified light distributions and SD separations potentially reducing the accuracy
and reliability of reconstructed flow contrasts as was described in Chapter 2.6.
These issues can be addressed in the future through computer simulations,
possible free-space corrections [80], and telecentric zoom lens incorporation [133,
134]. To improve results we additionally refined the mesh in the center region
around the known cubical heterogeneity location.
Compared to our previous ncDCT design, this system demonstrated potential
for fast and dense boundary data acquisition and deep tissue hemodynamics
tomography translating directly to human studies (e.g., burn/ulcerous tissue flow
detection). However, as the scDCT was designed primarily to further the CCDbased detection and novel speckle contrast flow detection some features are
limited. The contact-based source fibers are undesirable in practice due to
compression-induced hemodynamic and optical property changes [77, 78],
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potential situations of wound sensitivity and exposure, being restricted to outside
the camera FOV, and the difficulties in greatly increasing their quantity. This
system is also not capable of imaging fluorescence distributions. A fully noncontact
scDCT (nc_scDCT) has been developed and combined with DFT capabilities in
the next chapter concerning the final instrumentation which performs both flow and
fluorescence imaging.
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CHAPTER 4 NONCONTACT SPECKLE CONTRAST DIFFUSE
CORRELATION AND DIFFUSE FLUORESCENCE TOMOGRAPHY

4.1 Introduction

In this chapter advancements have been made to purpose a prototype diffuse
optical instrument in which all the beneficial operational characteristics including
noninvasiveness, reflectance mode, noncontact, translational, and sensitivity to
both flow and fluorescence changes are borne conjointly. The extension builds
upon the designs and techniques of ncDCT and scDCT and its noncontact version
(nc_scDCT) as described first. The role of ICG as our fluorescent agent of choice
and the related implications is supplied. The chapter is rounded out by the custom
designed experimental setup and protocol for executing a combined flow and
fluorescence contrast validation. A separate publication illustrated the independent
nc_scDCT instrumentation and its testing in vivo [100].

4.2 Multimodal Noncontact Speckle Contrast Diffuse Correlation and
Diffuse Fluorescence Tomography Prototype

A scanning galvo-mirror (GVS002, Thorlabs, NJ) was added for directing laser
source light around the FOV in noncontact fashion (Figure 4.1). As this and the
following supporting elements remove the static optical fiber source positioning
present with scDCT, the method is termed noncontact scDCT (nc_scDCT) [100].
To situate the galvo-mirror at a versatile vantage point, a metal support abreast of
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the CCD camera and out of the FOV was machined and installed. Detection of
potential source light reflections from the sample surface which have not travelled
through the tissue are minimized by installation of cross polarizers. The first
polarizer (LPNIRE050-B, Thorlabs, NJ) is interposed between a lens doublet at the
source fiber connector and the galvo-mirror. The second polarizer (LPNIRE200-B,
Thorlabs, NJ) is placed in a stackable tube (SM2L05, Thorlabs, NJ) in the path of
detected light at the zoom lens entrance.
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Figure 4.1: Combined nc_scDCT and DFT instrumentation. A laser source fiber
directs light into a lens and polarizer before being redirected to the sample surface
by the galvo-mirror. Light having travelled through the tissue and reflected from the
surface passes through two stackable tubes before interacting with the zoom lens
and CCD. The initial tube contains either a 775nm bandpass filter (775BP) or
800nm longpass filter (800LP). The proceeding tube contains a polarizer in cross
orientation with the source polarizer to remove reflected light.
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In order to isolate the different signals of interest one of two stackable tubes is
placed in front of the polarizer at the zoom lens at any given time. For acquiring
𝐵𝐹𝐼(785𝑛𝑚) or 𝜇𝑎 (785𝑛𝑚) a 775 nm bandpass filter (775BP; 86-968,
EdmundOptics, NJ) is placed in one stackable tube. For acquiring 𝐵𝐹𝐼(830𝑛𝑚),
𝜇𝑎 (830𝑛𝑚), or 𝜂𝜇𝑎,𝑓𝑙 an 800 nm longpass filter (800LP; 84-762, EdmundOptics,
NJ) is placed in another stackable tube. These stackable tubes are manually
exchanged as necessary during experimentation along with the appropriate laser
source. The polarizers remain in place throughout operation.

4.3 Indocyanine Green and Source Light

Indocyanine green (ICG) is a frequently used and documented fluorescent dye
in the NIR spectrum [16, 17, 19, 30, 33, 35, 135]. It is also FDA approved and
relatively inexpensive. The excitation and emission spectrum of ICG in whole blood
are shown in Figure 4.2. In our liquid phantoms we incorporate water, Intralipid
(primarily water), and ink (primarily water) which comprising a primarily aqueous
solution can diminish the fluorescent properties after ~6 hours. The experimental
protocol in this study therefore confines the total experiment duration (once ICG is
prepared in aqueous solutions) to within this interval. Furthermore, our preliminary
testing in similar phantom arrangements to those used herein suggested that the
785 nm laser (as used with scDCT; Chapter 3) produced adverse flow results at
high ICG concentrations. An 830 nm laser (as used with ncDCT; Chapter 2) was
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therefore also incorporated for comparison due to its increased distance from the
ICG absorption peak (Figure 4.2).

Figure 4.2: ICG and laser sources. The normalized excitation and emission
curves of ICG are shown with the wavelengths of the two laser sources (785 and
830 nm) used. It is expected that the 830 nm laser 𝐵𝐹𝐼 recovery will exhibit a
diminished influence from the presence of ICG due to its location lower in the
absorption/excitation spectrum.

4.4 Experimental Setup

The noncontact source/detection apparatus is located directly above a
container filled with liquid phantom background, 𝜇𝑎 (785𝑛𝑚) = 0.05 𝑐𝑚−1,
𝜇𝑠′ (785𝑛𝑚) = 7.0 𝑐𝑚−1 , 𝐷𝐵 ≈ 1 × 10−8 𝑐𝑚2 /𝑠, and centrally stationed custom
hinged structure for holding and swapping contrast elements (Figure 4.3). The

64

flow contrast was provided by a 6 mm side length solid cubical phantom,
𝜇𝑎 (785𝑛𝑚) = 0.05 𝑐𝑚−1, 𝜇𝑠′ (785𝑛𝑚) = 7.0 𝑐𝑚−1 , 𝛼𝐷𝐵 approximately three orders
of magnitude lower than background as measured previously [125], submerged at
2 mm depth on one side of the 60 mm × 60 mm FOV. Fluorescence, and inherently
absorption, contrasts were created by tubes (5.9 mm outer diameter, 5.3 mm inner
diameter; PRT00074, ClearTec Packaging, MO) filled with liquid phantom
background and a varying concentration of ICG. They were submerged (one per
each step) at 2 mm depth with concentrations in steps from 0.0625 – 4 µM in
doubling fashion for a total of 8 steps (plus one step of 0 µM) on the opposite side
of the FOV. This concentration range agrees with typical diffuse optical
applications in the literature and includes the maximum ICG fluorescence signal
(~1 μM) before it proceeds to decrease with further concentration increases. With
reference to the coordinate system centered in the FOV (0, 0, 0) as the x-y plane
on the surface at depth z = 0 mm, the solid cube center was (-9.74, 0, 5.0) and
tube center (12.3, …, 5.0; extending effectively indefinitely outside the FOV in the
y direction).
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Figure 4.3: Experimental setup for multimodal system testing. A liquid
phantom background pervades a container centered around the camera FOV (blue
dashed line). A custom holder also centered enables fast switching of flow (cubical
solid phantom) and fluorescence/absorption (liquid-containing tubes) contrasts in
the left and right regions, respectively.

4.5 Data Acquisition Procedure

Prior to data collection several preliminary tasks were performed. The
container was placed in the camera FOV with the hinged structure centered. The
liquid phantom background was then created with Intralipid, India ink, and distilled
water as done in our earlier studies (see Chapter 3). This was used to fill the
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container to a level 2 mm above the designated areas for cube and tube insertion.
A single tube of 115 mm length was filled with the liquid phantom background
solution and placed as designated in the hinged structure along with the solid
phantom cube. The displacement of the surface level due to the added
heterogeneities was negligible. Some liquid was removed temporarily to acquire a
reference image of the heterogeneity layout as shown in Figure 4.4.

Figure 4.4: Heterogeneity layout. A reference image of the positioning of flow
(cube) and fluorescence (tube) contrasts prior to data collection. Data outside the
dashed frame is within the FOV, but excluded from analysis. The surface level of
the liquid phantom background was reduced only for this image.
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After restoring the surface level and removing heterogeneities, the 785 nm
laser source was applied. The galvo-mirror scan offsets to achieve a 9 × 9 grid of
source positions were determined covering the 60 mm × 60 mm FOV. A set of
images were acquired for post-analysis calculation of the source positions. This
was repeated for the 830 nm laser along with verifying the scan settings and
coverage area (Figure 4.5).

Figure 4.5: Source-Detector layout for 785 and 830 nm. The 9 × 9 source
(circles) and 41 × 41 detection (crosses) grids for (a) 785 nm and (b) 830 nm
lasers.
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Eight 115 mm length tubes were then filled with ICG in the following fashion. A
base dye solution of 15.48 µM was created with 1.2 mg of ICG (MW: 775 g/mol)
and 100 ml of the surplus liquid phantom background. The remaining surplus liquid
phantom background, in a separate container, was brought up to the first step of
0.0625 µM ICG concentration using the base dye solution. An aliquot was then
taken to fill a single tube. The base dye solution was added again to the primary
solution for 0.125 µM and an aliquot placed in the second tube. This was repeated
to fill the remaining six tubes, up to 4 µM.
The final preliminary objective was in establishing the exposure times for
fluorescence and absorption measurements. The maximum concentration tube
was placed in the structure along with the solid phantom cube. Exposure times
were varied until the highest intensities were ~90% max (of 16-bit digitization;
~59,000 counts). This increased the available signal while remaining below the
level of pixel saturation. To accomplish this a program was written in MATLAB to
mask and plot the intensity data in an SD range-delimited annulus for visualization.
The flow exposure time was restricted in that it has an inherent relation with the
flow dynamics – the value was selected based on our nc_scDCT study [100].
Each step consisted of five unique system setups as shown in Table 4.1. This
row arrangement is maintained in actual data collection sequencing (Figure 4.6)
to minimize transition time (e.g., switching filter and/or laser). An initial step not
otherwise depicted consisted of the flow baseline step which included the 0 µM
tube only (i.e., no cube present). Subsequent data collection then consisted of
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acquiring data for each variation in tube concentration while the cube remained
unhindered.

Table 4.1: System collection parameters at a single step
Target

Exposure
Time (ms)

# Frames

Frame
Rate (fps)

Filter

Laser
Source (nm)

𝜂𝜇𝑎,𝑓𝑙

750

4

1.4

800LP

785

𝜇𝑎 (785 𝑛𝑚)

15

10

8

775BP

785

𝐵𝐹𝐼(785 𝑛𝑚)

5

10

8

775BP

785

𝐵𝐹𝐼(830 𝑛𝑚)

5

10

8

800LP

830

𝜇𝑎 (830 𝑛𝑚)

25

10

8

800LP

830
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Figure 4.6: Data acquisition sequencing. The data collection is depicted at the
top with a single complete step consisting of the simultaneous presence of the
solid cube and a tube with 0 µM ICG. This is repeated for each step of increasing
fluorescence up to the final step (solid cube plus 4 µM tube). The attached filters
are identified as well as the corresponding source wavelengths, exposure times,
and number of frames collected.
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The data acquisition for an individual signal was automated through the
complete set of 81 source positions using a customized LabVIEW program once
the appropriate laser source and filters were attached. The automation was (for
each position): set galvo-mirror offset values, signal galvo-mirror to move, wait 100
ms, trigger camera, wait for exposure completion, wait for frame readout
completion. The camera control program (open source µManager, Open Imaging)
was set to acquire the appropriate number of images.
To process the data, a 41 × 41 grid of logical detectors was identified to span
the source grid area of the corresponding source (see Figure 4.5). Detectors were
separated by 1.25 mm. Each source position was found by averaging the row and
column indices for intensities greater than half max from the reference images
collected at the beginning of the protocol. This is on the assumption that the
intensity is roughly symmetric and falls away from the center in a radial (and
exponential) manner. Ultimately, we end up with 136,161 possible SD
arrangements. The actual data used in reconstructions was restricted by SD
separation to limit noise while probing up to the requisite depth sensitivity of the
contrast elements. With a sensitivity of ~1/2 SD separation, heterogeneity depth
up to 8 mm, and increasing noise/decreasing signal at large SD, the SD range was
limited to 16 mm. The lower end criteria excluded data close to the source (< 7
mm) where the data tends to deviate from expectations as experienced in previous
investigations. This SD range was kept consistent for all boundary data processing
and reconstructions (e.g., flow, fluorescence, and absorption).
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The post-analysis processing of data is shown in Figure 4.7. The processing
overlaps in several ways such as dark correction, low-pass (Gaussian) filtering,
and averaging data across frames. The flow and absorption data were smear
corrected due to the order of the exposure time being near that of the frame
transfer time (see Chapter 3). For all sets of information, the basic data was
considered as that calculated in a 7 × 7 window. This was averaged over a 21 ×
21 block in the neighborhood of each effective detector. The resulting values were
then averaged across the collected frames. A detector position was established as
the center of its corresponding block. For flow, the reconstruction process requires
an estimated 𝛼𝐷𝐵 at each SD pair which is determined by the semi-infinite based
speckle contrast minimization (see Chapter 3). Calibration for flow was performed
by applying calibration factors to boundary data as obtained from the baseline step
where flow is homogeneous throughout (𝛼𝐷𝐵 ≅ 1 × 10−8 cm2/s). The fluence
boundary data for absorption was calibrated to the forward solution in NIRFAST of
the homogeneous baseline step with known absorption coefficients. The
fluorescent fluence boundary data was subtracted from the baseline step (i.e., no
fluorescence) to remove the excitation signal.
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Figure 4.7: Flow diagram of data processing. The diagram charts the path of
data along various levels of processing for flow, fluorescence, and absorption.

Absorption reconstructions are analogous to those of flow as outlined in
Chapter 2.4. The substitution of 𝐺1 by Φ and setting 𝜏 = 0 provides the formally
equivalent set of steps. These features are already provided within the FEM
framework in NIRFAST [105, 110]. FEM fluorescence reconstructions also
resemble those of absorption/PDE as can be seen by the similarity of the CW PDE
(Equation 1.1) and coupled fluorescent diffusion equations (Equations 1.2 and
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1.3). The formal definitions include comparable Robin boundary conditions, FEM
discretization, and matrix equations where the source vector for the emission
wavelength is expressed in terms of the (CW) excitation fluence 𝑆𝑓𝑙,𝑖 =
∫Ω 𝜓𝑖 Φ𝑒𝑥 𝑑Ω, and the updating procedure includes both the excitation absorption
𝛿𝜇𝑎,𝑒𝑥 and the fluorescence yield 𝛿𝜂𝜇𝑎,𝑓𝑙 as described in detail elsewhere [136]
and is also already included in NIRFAST.
The flow and absorption reconstructions used a mesh of [dimensions (mm): 70
(H) × 70 (W) × 30 (D)] with 31,091 nodes at 1.05 mm node distance. The
fluorescence had a mesh of reduced node numbers due to memory requirements.
The corresponding mesh had [dimensions (mm): 70 (H) × 70 (W) × 30 (D)] with
7,094 nodes at 2 mm node distance. In addition to SD range limits, edge regions
were masked from SD pairs as shown in the outline in Figure 4.4. There were a
total of 81 source and 1,681 detector positions used in all reconstructions with
17,912/16,823 valid SD pairs for 785/830 nm sources. The average number of
iterations and reconstruction times (minutes) for flow, fluorescence, and absorption
are shown in Table 4.2. All reconstructions used a [20 20 20] pixel basis for the
secondary mesh with 8000 nodes (used in calculating the Jacobian and update
per iteration). Flow distributions are reported as nodal 𝑟𝐵𝐹 = 𝛼𝐷𝐵 /𝛼𝐷𝐵,0 where
𝛼𝐷𝐵,0 are the nodal values from the 0 µM tube, absent solid cube step.
Fluorescence results are reported as nodal 𝑟𝜂𝜇𝑎,𝑓𝑙 = 𝜂𝜇𝑎,𝑓𝑙 /(𝜂𝜇𝑎,𝑓𝑙 )

0

where

(𝜂𝜇𝑎,𝑓𝑙 ) is the baseline step of 0.0625 µM tube with cube present. Absorption
0

results are reported as actual recovered nodal values.
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Table 4.2: Reconstruction iterations and times
Reconstruction Time
(minutes)

# Iterations
Reconstruction
785 nm

830 nm

785 nm

830 nm

Flow

13.7 ± 0.8

13.1 ± 0.3

59.4 ± 2.8

52.9 ± 4.0

Fluorescence

50.6 ± 6.9

-

704 ± 96

-

Absorption

10.0 ± 3.8

11.2 ± 3.7

45.7 ± 17.0

46.1 ± 14.5

4.6 Results

The fluorescence distributions recovered at each step of varying ICG
concentration are shown in Figure 4.8. The tube shown was separated from
background by a threshold of three standard deviations above the mean. The
detection and localization capabilities are evident with the tube clearly separated
from the background and in the region expected. The characterization of the tube
shape is distorted in appearance but has similarity to a tube with the proper
orientation. This inadequacy is due in part to the lower density mesh used in
fluorescence reconstructions. The characterization of relative fluorescence
changes involved normalization of the extracted heterogeneity average
fluorescence per step to the middle of the tested range (1 µM) as shown in Figure
4.9. These values are compared to the expected values with good agreement. The
larger deviations at higher concentrations is likely caused by the self-quenching
and diminished signal of ICG at concentrations greater than 1-2 µM resulting in
underestimations in comparison with the strict trend used. Additionally,
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inaccuracies in the preparation of ICG may result in the absolute concentrations
being lower/higher than expected. Extracting small amounts of solid ICG for
placement in the aqueous base solution created an uncertainty in the mass with
true value in the range of 1.2 ± 0.2 mg. Due to the instability of ICG in water,
creating a large base solution for storage and reuse was not feasible.
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Figure 4.8: Recovered fluorescence images. The heterogeneity as recovered
by fluorescence distributions for each step of ICG variation.
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Figure 4.9: Recovered fluorescence changes. The heterogeneity average
fluorescence as recovered by fluorescence distributions for each step of ICG
variation in comparison with the expected changes (solid line).

The heterogeneity as extracted by absorption coefficient distributions are
shown for 785 nm and 830 nm in Figures 4.10 and 4.11, respectively. The
background and heterogeneity were separated by a threshold of three standard
deviations above the mean. The heterogeneity detection and localization with the
absorption coefficients were quite evident for 785 nm. Corresponding tube shapes
and orientations were also in agreement with the known situation. These
characterizations increasingly trended towards the tube properties with increasing
concentration. At the lowest concentrations (e.g., < 0.25 µM) the tube was difficult
to separate from the background with some noticeable erroneous inclusions. The
830 nm results have artifacts that are obfuscating the recovery of the true tube
data. However, at higher concentrations (e.g., > 1 µM) the increasing absorption
dominates and the conclusions coincide with that for 785 nm absorption
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coefficients. Using the threshold-extracted heterogeneity at each step, nodal
absorption coefficients were averaged and their change with ICG concentration is
shown in Figure 4.12. There is a 320% increase in 785 nm absorption over the
steps. The 830 nm absorption trend is inconclusive due to artifacts in the lower
ranges.
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Figure 4.10: Recovered 785 nm absorption. The 785 nm absorption coefficient
distributions are shown for each step of ICG variation for the extracted
heterogeneity.
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Figure 4.11: Recovered 830 nm absorption. The 830 nm absorption coefficient
distributions are shown for each step of ICG variation for the extracted
heterogeneity.
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Figure 4.12: Recovered absorption coefficient changes. The nodal average of
absorption coefficients as recovered from the threshold-extracted heterogeneity at
each step.

Further characterization includes the tube depth and lateral position as shown
in Figure 4.13 for the fluorescence and absorption coefficient extracted
heterogeneities at each step. The depth is calculated as the z-coordinate of the
center of mass (nodal weighted fluorescence or absorption coefficient). The lateral
position similarly is by the x-coordinate of the center of mass. As the tube extends
outside the FOV, the y-coordinate is not specified but instead the agreement was
visualized in Figures 4.8, 4.10, and 4.11. The tube depth was most successfully
recovered by the fluorescence signal with an average percentage error of 41%
whereas 785 nm absorption was 74% error (830 nm data insufficient). The
increasing signal with fluorescence did not correct the depth estimate. This is due
in part to the sampling density and that ICG (MW 775 g/mol) may have
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preferentially accumulated at the bottom of the tube (primarily water: MW ~18
g/mol). The lateral positioning did, however, show a gradual improvement with
concentration.

Figure 4.13: Characterized tube properties. The (a) tube depth (center of mass
z-coordinate) and (b) lateral position (center of mass x-coordinate) are shown
based on the recovered fluorescence and absorption coefficients. The actual value
is provided by a solid line for comparison.
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In the case of flow, we expect the reconstructed heterogeneity to resemble a
cube and present with low flow values with respect to the background. The flow
heterogeneity as extracted by half-minimum threshold is shown for 785 nm and
830 nm in Figures 4.14 and 4.15, respectively. The cube is detected and localized
in the appropriate region by both wavelengths at low concentrations of ICG. A
noticeable disturbance in the tube region arises at ~0.25 µM for 785 nm and ~1
µM for 830 nm. The size of the disturbance increases with the graduation of ICG
concentration. The derived cube center of mass, averaged 𝑟𝐵𝐹, and average side
lengths are shown in Figures 4.16 and 4.17. This data excludes the region of
disturbance and only pertains to the cube properties. The x and y coordinates were
near to the true values with offsets of: 1.7 ± 0.46, 1.7 ± 0.38 mm and 0.67 ± 0.24,
0.52 ± 0.22 mm, respectively for 785/830 nm. This coincides with the square
appearance of the upper portion of the recovered cube shape. Depth recovery for
785/830 nm was off by 4.0 ± 0.09, 3.8 ± 0.06 mm over all cases as reflected in the
z center of mass coordinate and recovered shape. The threshold chosen was
based on previous studies as well as the best recovery of the cube as judged
across all steps. Modifying the threshold and increasing the sampling density in
the cube region can improve characterization. The heterogeneity 𝑟𝐵𝐹 was
consistent throughout all steps with 785 nm (0.41 ± 0.05) higher on average in
comparison with 830 nm (0.31 ± 0.07). Both values dropped after the first step
suggesting some vestiges of motion lingered from the early setup stages. As all
relative flow values depend on the first step, it is expected that the difference
between the recovered flow in the first step from both wavelengths persisted
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through the remaining steps once the phantom had stabilized. The relative flow
values agreed with previous measurements. The last metric characterized was the
average side length. While 830 nm exhibited a nearly constant recovered side
length (5.0 ± 0.55 mm), 785 nm (3.9 ± 1.2 mm) had strong influences due to the
ICG presence (> ~0.25 µM). The inaccuracy in depth and corresponding “depth
side length” contribution is likely the cause of both wavelengths’ underestimation
of the average side length in all cases.
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Figure 4.14: Recovered 785 nm flow. The heterogeneity as recovered by flow
distributions with a half-min threshold for extraction over all steps.
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Figure 4.15: Recovered 830 nm flow. The heterogeneity as recovered by flow
distributions with a half-min threshold for extraction over all steps.
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Figure 4.16: Cube location. The results of the recovered cube center of mass
coordinates from the extracted flow heterogeneity at each step. The 0 μM step is
represented as 0.01 μM for visualization on the log scale.
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Figure 4.17: Cube characteristics. The (a) average rBF and (b) average side
length from the heterogeneity extracted at each step from flow distributions. The 0
μM step is represented as 0.01 μM for visualization on the log scale.
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4.7 Observations and Limitations

The results of this study provide insight into the feasibility of applying this
prototype multimodal diffuse flow and fluorescence imaging system into recovering
a combined tomographical set of parameters. The instrumentation possesses all
the features desired in the outset, namely noncontact, noninvasive, translational
potential, flexible design, reflectance mode, and important flow and fluorescence
endpoint information. The incorporation of the novel nc_scDCT design provided
enhanced sampling density and SD patterns over previous implementations. The
addition of diffuse optical tomography techniques during experimentation has
given prescience to problematic circumstances that may occur under application
of this new device. Explication into the outcomes, reconciliations, and limitations
will elucidate these findings.
There are two major time obstructions in this study, to be evaluated on a case
by case basis in future studies, which are the stepwise and total experimentation
times. For an individual step there is a tradeoff regarding bottleneck factors
including the maximum camera frame rate, long fluorescence exposure time,
source position number/density, and frame number (see Figure 4.5 and Table
4.1). The camera frame rate can be improved by camera selection and binning. To
retain a full set of pixel information we did not use binning. The fluorescence
exposure time is an order greater than that used for absorption and two orders for
flow. As the fluorescence signal is generally only a small fraction of the original
signal one may seek to maximize filter quality, fluorescence concentrations,
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excitation intensity, camera sensitivity, and use a fluorescent agent with greater
quantum yield. The signal increase with fluorescence concentration may peak as
is the case with ICG around 1-2 µM. An increase in source positions can probe a
greater amount of detail from the sample. As the purpose of this study was to
combine detection and characterization, we selected a distributed source pattern
that included both homogeneous and heterogeneous regions. The data from each
source must be taken independently due to the point-like source and detection
models incorporated. Too many source positions may result in subject movement
artifacts, physiological changes, and computational overhead. These timeconsuming options are then protracted by the number of frames collected. The two
sources as employed in this study add a multiplicative layer to this envelope. The
total experimentation time is then, under the assumption that each step is identical
in collection, scaled by the number of overall steps. For example, increasing the
number of concentrations tested would greatly increase the total duration. The
upper limit was the stability of ICG in aqueous solutions at approximately 6 hours.
In clinical studies, the stability of ICG in plasma and whole blood is not a significant
factor but the clearance rate and desired temporal resolution will intimate the
governing constraints.
The most observable deviation from expectations was the disturbance of flow
recovery with increasing ICG concentrations (see Figures 4.14 and 4.15). The
source of this influence is not allocated to the fluorescence signal which is both
filtered and inherently significantly weaker than the excitation light. The
accompanied absorption coefficient changes are conversely known to cause
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errors in diffuse correlation flow analysis [112, 118]. Specifically, an
underestimation of the absorption coefficient results in an underestimation in the
flow. As the absorption coefficient in the ICG tube is continually increasing (see
Figure 4.12) it is expected that our use of the background value for fluorescence
reconstructions is leading to an underestimate in flow. Therefore, the ICG region
is promoting a drop in flow boundary data that is not due to any actual flow
presence. As the referenced results analyze DCS rather than scDCS, typical
parameters were used to show they are similarly affected (Figure 4.18). In most
blood flow studies involving diffuse optics the relative blood flow over time is
unchanged regardless of the absorption coefficient value. However, these are with
the expectation that there are no changes during the experiment/interval. In the
case of changing ICG the absorption coefficient is not static and therefore can
introduce uncertainties in the results. The extent of influence depends both on the
level of absorption coefficient change as well as the measurement in question. One
must note the potential implications both on spatial and temporal heterogeneities.
In this study, we only looked at flow relative to an otherwise homogeneous
absorption background and with the flow and ICG in separate regions.
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Figure 4.18: Comparison of DCS and scDCS errors with absorption
coefficient. The percentage errors between the actual and recovered blood flow
index by DCS (g2) and scDCS (𝐾 2 ; multiple exposure times) in typical
circumstances over increasingly underestimated absorption coefficients. In this
study, a 5 ms exposure time for flow corresponds to the region between the red
and blue solid lines.

To minimize the absorption change influence on flow results, we consider
several counteractions by means of system modification, context leveraging, or
measurement protocol adjustment. Two system additions were integrated in the
current study: adding a second laser source (830 nm) at a different wavelength
from that used to induce a strong fluorescent signal (785 nm), and monitoring 𝜇𝑎
changes with DOT. When selecting a separate source for flow we enlist a
wavelength outside of the maximum region of ICG absorption. From Figures 4.14
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– 4.17, the 830 nm with a lower position in the ICG excitation spectrum (Figure
4.2) did offer an improvement in flow results. A source on the lower end, around
660 nm, is another option. The accompanying optical properties will, however,
inhibit in other ways including increased scattering at lower wavelengths and
increases in chromophore absorption at both ends of the NIR spectrum (Figure
1.1). In either case, there will be two laser sources required which can greatly
increase data acquisition time as described earlier. We also added DOT to append
our parameter set with the absorption changes. From this we found a large
absorption change (Figure 4.12). In practice, by reviewing this concurrent
information post-measurement volumes of large absorption change may be
marked unreliable and removed from further analysis. We would first need to select
a threshold for what constitutes a large absorption change (e.g., use estimates for
DCS [118] or perform equivalent scDCS analysis) as well as remove all flow
boundary data that is sensitive to the region(s) effected. In real tissues this solution
could become intractable due to heterogeneous distributions, DOT measurement
uncertainties, and the ability to perform reconstruction adequately with remaining
data. In such circumstances the flow data would be completely disregarded. The
ability to add CW DOT is straightforward with the combined system as the laser
source and filter are already implemented. There is, of course, the additional
overhead of collecting the DOT data which can inhibit the temporal resolution.
System modifications may not be necessary if, by experience, we already know
the ICG absorption to fluctuate only within a small range (as the absorption
contrast itself is a popular use of ICG). In practice, the fluorescence is usually
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examined in relative fashion and can be subject to pH and tissue microenvironment
variations and therefore is in general, by itself, an insufficient indicator of feasibility.
Other fluorescent agents than ICG require individual examination. Finally, one
might simply acquiesce to the possibility of unresolvable absorption interference
and restrict flow measurements to pre-fluorescence injection and post-clearance
(or the phantom equivalent). We note here for completeness that the reduced
scattering coefficient has an even greater influence on flow recovery than the
absorption coefficient, but that there is no expected introduction of significant
scattering changes due to ICG [135]. An additional consideration is the red-shifting
of ICG absorption in plasma as opposed to the aqueous solution tested (Figure
4.2).
The computing resources for processing the fluorescence data surpassed that
available for our reconstruction computer (2.80 GHz i7-7700HQ, 32.0 GB memory)
requiring a mesh of decreased density. This is primarily due to the implementation
building a pre- and current-iteration Jacobian which collectively has greater
memory requirements than the standard CW DOT or flow reconstructions. For the
standard reconstructions a conjugate gradient alternative is available to reduce
memory expense with a longer reconstruction time but was not implemented for
fluorescence at the time of this study. It is technically simple to convert a mesh
created for flow to that for absorption and fluorescence given they are all in
MATLAB and can be done in future studies to have a directly comparable set of
mesh information. Use of supercomputing resources, Jacobian subsets, task
paralellization, GPU-based solvers, and fewer SD combinations can help relax
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overhead on mesh agreement and reduce computation times [137, 138]. The valid
SD combinations depend on both the source positions as outlined earlier as well
as the defined detectors. When selecting a detector grid we avoid touching (sideby-side) spacings which contribute marginal information in terms of the tradeoff for
spatial sampling. Increasing the detector number extends the reconstruction time
and necessary resources.
We conclude that with this prototype we illustrated the ability to extract flow
and fluorescence, but that the situation in practice is complex and requires care in
properly setting up, acquiring, and consuming the information. In the next chapter
we look towards the future and areas of improvement.
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CHAPTER 5 STUDY SUMMARY, LIMITATIONS, AND FUTURE
PERSPECTIVES

5.1 Study Summary

In this dissertation, I presented a progression of continuously advancing diffuse
optical devices towards the noncontact reflectance imaging of 3D flow and
fluorescence distributions in deep tissues/phantoms. The initial ncDCT system
with its mechanical scanning apparatus, complex boundary acquisition methods,
and new FEM flow reconstruction technique provided a useful first generation of
completely noncontact flow imaging capability. This instrument was applied to a
small animal aggressive breast tumor model highlighting the potential for
longitudinal reflectance flow imaging for visualization and relative quantification of
cancerous

microvascular

developments.

The

successor

scDCT

system

demonstrated a movement to CCD-based light detection for improved spatial and
temporal detector sampling, a uniquely requisite smear correction, and speckle
contrast flow measurement. Testing illustrated a sensitivity to the presence of high
flow contrast and subsequent characterization. The final multimodal nc_scDCT
and DFT prototype made its province with the best features of both the previous
systems along with related noncontact scDCT developments. With this fully
noncontact source and detector arrangement and filter set, high contrast flow and
fluorescent heterogeneities were identified and characterized in tissue-like
phantoms.
The novel nc_scDCT/DFT system embodies all the desirables proposed in the
outset. The potential for new cancer studies are extensive, especially by coupling
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the realm of nanoparticles. For example, nanoparticles may be repletely tagged
and monitored as drug carrying vehicles or, alternatively, designed to improve
tumor targeting for the proper localization of the fluorescence signal itself. As the
vasculature is the most common route of conveyance for transporting agents
throughout the tissues (as opposed to site injection for example), analyzing
corresponding blood flow variations can offer new insights into the underlying
factors contributing to nanoparticle success or failure. With the new instrument we
can now build upon the already established advantages of the diffuse optical
methods in cancer imaging.
My major contributions to the studies herein are as follows:
ncDCT. I had primarily a supporting role in the development of ncDCS/ncDCT
instrumentation, source and detector alignment on complex boundaries, and
ncDCT application to breast tumors. My major contributions in respect to ncDCT
concern its application to small animal tumors. I performed all animal ncDCT
measurements, image reconstructions, and analysis (Chapter 2.6). I was able to
find average tumor flow changes and volumes after a four-day gap for a mouse
with two palpable tumors. The localization and separation of tumor tissues relative
to healthy tissues was also described along with numerous observations for
enhancing future studies of a similar nature.
scDCT. Forwarding the transition from APD to CCD detection I derived the
relationship between speckle contrast and the semi-infinite form of the electric field
temporal autocorrelation function as modeled by the correlation diffusion equation
(Equations 3.1 – 3.9; Chapter 3.3). I also worked with a vendor to obtain a
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customized optical switch to fulfill our requirements within the constraints and
wrote the LabVIEW program to operate it in sequencing light around the FOV for
phantom experimentation. Through meeting Cancer Nanotechnology Training
Center (CNTC) fellowship obligations (e.g., extra coursework, meetings, seminars,
clinical experience, reports, outreach activities, and journal club attendance), I
made available the funding for hardware (i.e., optical switch, zoom lens, DAQ
board, etc.), software (e.g., SolidWorks and TracePro), and supplies with $25,775
funding, $30,000 stipend, and $3,200 travel funding.
nc_scDCT/DFT. I supplemented previous scDCT/nc_scDCT system designs
with the necessary stackable tubes for combining the cross-polarizer and a set of
filters to instantiate a multimodal nc_scDCT/DFT prototype (Chapter 4). I designed
a flow and fluorescence experiment for verifying its proper operation. This included
building a custom hinged holder from a clear acrylic sheet. An experimental
protocol was carefully formed to exhibit the flow and fluorescence recovery within
the constraints of source/detector number tradeoff and arrangement, ROI
coverage, exposure time durations, frame averaging, and the number of steps to
evaluate. Programming was added to coordinate source laser position scanning
with varied exposure times and camera triggering. I performed all measurements,
analysis, and summarization of the flow and fluorescence detection and
characterizations. The CNTC fellowship also supported funding of components in
this study including the galvo-mirror, filters, lenses, alternative test setups
(involving filter wheels and lenses), and other related supplies.
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Other. My other significant contributions include the assistance in writing,
editing, and/or reviewing manuscripts, grant proposals, and presentations. I have
been involved in many other in vivo studies including clinical measurements of
human head and neck tumors prior to and during radiation therapy, breast tumor
imaging, peripheral arterial revascularization surgery, electrical stimulation blood
flow response, mouse leg cuff occlusion, and human subject orthostatic tolerance
by cardiovascular response to antigravity treadmill and bed tilting.

5.2 Study Limitations and Future Perspectives

Flow acquisition improvements. Acquiring flow by means of speckle
contrast from an image at a specific exposure time has its encumberments.
Specifically, the exposure time is minimally flexible due to its relationship with flow,
the aperture (f/#) is related to the smallest speckle size and Nyquist sampling, and
the laser source must possess a long-coherence length. These factors combined
limit the intensity. Utilizing the EM gain supplied by our highly sensitive EMCCD
camera should enhance the available signal and reduce the influences of noise
and promote repeatability. A camera with a greater frame rate will allow for more
frame averaging. The type of noise to be minimized will dictate the experienced
benefits of either such solutions.
Detection and characterization tradeoff. The testing of the multimodal
imager prioritized neither heterogeneity detection or characterization. This mixed
approach creates a situation where neither objective is optimized but rather a
balance is obtained. The accuracy of object characterization can be improved by
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taking more measurements near the heterogeneity such that most of the signals
detected have interacted with it. However, in practice we may not know where such
disturbances exist. As such, a spatially distributed set of SD pairs can be first
utilized to localize the object with follow up imaging of increased sampling density
in the target ROI’s.
Device automation. The prototype nc_scDCT/DFT did not employ full
automation. The extension thereof is expected to be straightforward with mostly
time overhead. The filters can be exchanged dynamically with an appropriate
motorized filter wheel for 2-inch diameter lenses. The laser sources can be
alternated by the optical switch. The optical switch was not used during the current
study so as to maximize flow signal. Combining the switch with the aforementioned
flow signal compensations can make this feasible. Both the filter wheel and optical
switch will incur some programming support for proper operation. Ultimately, this
will provide the most robust system as originally conceptualized.
Flow reconstruction. The current flow reconstruction technique though useful
couples the blood flow index reconstruction to the absorption coefficient in an
undesirable fashion. It is anticipated that deriving an adjoint Jacobian formulation
and corresponding update for flow specifically can improve flow imaging. This will
not obviate the concerns regarding absorption changes. As is evident from the
adjoint formulation, the absorption and reduced scattering coefficients continue to
contribute to the sensitivity. Further investigation into L-curve analysis may also
prove beneficial in optimizing selection of the reconstruction iteration to clarify the
adequacy of assuming this method for the combined total absorption.
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APPENDIX: GLOSSARY

Notations/
Terms

Description

𝛼

Ratio of dynamic to total scatterers

𝛼𝐷𝐵

Blood flow index (𝐵𝐹𝐼)

𝛽

Factor related to speckle and collection optics

𝜖𝑒𝑥

Fluorophore extinction coefficient

𝜂

Fluorescence quantum yield

𝜂𝜇𝑎,𝑓𝑙

Fluorescent yield

𝜆

Wavelength

𝜇𝑎

Absorption coefficient

𝜇𝑎,𝑒𝑥

Absorption coefficient (excitation)

𝜇𝑎,𝑓𝑙

Absorption coefficient (emission)

𝜇𝑎𝑡𝑜𝑡𝑎𝑙

Total absorption coefficient

𝜇𝑠′

Reduced scattering coefficient

𝜈

Speed of light in tissue

𝜌

Source-detector separation

𝜏

Correlation delay time

Φ

Photon fluence

Φ𝑒𝑥

Photon fluence (excitation)

〈∆𝑟 2 (𝜏)〉

Mean-square scatterer displacement

𝐵𝐹𝐼

Blood flow index (𝛼𝐷𝐵 )
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𝐷

Photon diffusion coefficient

𝐷𝑒𝑥

Photon diffusion coefficient (excitation)

𝐷𝑓𝑙

Photon diffusion coefficient (emission)

𝐷𝐵

Scatterer diffusion coefficient

𝐺1

Unnormalized temporal electric field autocorrelation function

𝑔1

Normalized temporal electric field autocorrelation function

𝐺2

Unnormalized temporal intensity autocorrelation function

𝑔2

Normalized temporal intensity autocorrelation function

𝐼

Intensity

𝑘0

Wavenumber

𝐾

Speckle contrast

𝑛

Index of refraction

[𝑁]

Fluorophore concentration

𝒓

Position vector

𝑟𝐵𝐹

Relative blood flow

𝑅𝑒𝑓𝑓

Effective reflection coefficient

𝑇

Exposure time

CW

Continuous wave

DCS/T

Diffuse correlation spectroscopy/tomography

DFS/T

Diffuse fluorescence spectroscopy/tomography

DOS/T

Diffuse optical spectroscopy/tomography

fps

Frames per second
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ICG

Indocyanine green

ncDCS/T

Noncontact diffuse correlation spectroscopy/tomography

nc_scDCT

Noncontact speckle contrast diffuse correlation tomography

NIR

Near infrared

scDCS/T

Speckle contrast diffuse correlation spectroscopy/tomography

SD

Source-Detector separation

105

REFERENCES

[1]

D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next
generation," Cell, vol. 144, no. 5, pp. 646-74, Mar 4 2011.

[2]

P. Vaupel, F. Kallinowski, and P. Okunieff, "Blood flow, oxygen and nutrient
supply, and metabolic microenvironment of human tumors: a review," (in
eng), Cancer Res, vol. 49, no. 23, pp. 6449-65, Dec 1 1989.

[3]

C. B. Wilson et al., "Quantitative measurement of monoclonal antibody
distribution and blood flow using positron emission tomography and
124iodine in patients with breast cancer," (in eng), Int J Cancer, vol. 47, no.
3, pp. 344-7, Feb 1 1991.

[4]

H. Madjar, W. Sauerbrei, H. J. Prompeler, R. Wolfarth, and H. Gufler, "Color
Doppler and duplex flow analysis for classification of breast lesions," (in
eng), Gynecol Oncol, vol. 64, no. 3, pp. 392-403, Mar 1997.

[5]

M. A. Hahn, A. K. Singh, P. Sharma, S. C. Brown, and B. M. Moudgil,
"Nanoparticles as contrast agents for in-vivo bioimaging: current status and
future perspectives," Anal Bioanal Chem, vol. 399, no. 1, pp. 3-27, Jan
2011.

[6]

V. Saxena, M. Sadoqi, and J. Shao, "Indocyanine green-loaded
biodegradable

nanoparticles:

preparation,

physicochemical

characterization and in vitro release," Int J Pharm, vol. 278, no. 2, pp. 293301, Jul 8 2004.

106

[7]

R. Tong, H. H. Chiang, and D. S. Kohane, "Photoswitchable nanoparticles
for in vivo cancer chemotherapy," Proc Natl Acad Sci U S A, vol. 110, no.
47, pp. 19048-53, Nov 19 2013.

[8]

R. K. Jain, "Delivery of molecular and cellular medicine to solid tumors," Adv
Drug Deliv Rev, vol. 46, no. 1-3, pp. 149-68, Mar 1 2001.

[9]

S. Eliasof et al., "Correlating preclinical animal studies and human clinical
trials of a multifunctional, polymeric nanoparticle," Proc Natl Acad Sci U S
A, vol. 110, no. 37, pp. 15127-32, Sep 10 2013.

[10]

T. Lei, A. Fernandez-Fernandez, R. Manchanda, Y. C. Huang, and A. J.
McGoron, "Near-infrared dye loaded polymeric nanoparticles for cancer
imaging and therapy and cellular response after laser-induced heating,"
Beilstein J Nanotechnol, vol. 5, pp. 313-22, 2014.

[11]

H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, "Tumor vascular
permeability and the EPR effect in macromolecular therapeutics: a review,"
J Control Release, vol. 65, no. 1-2, pp. 271-84, Mar 1 2000.

[12]

M. Ferrari, "Cancer nanotechnology: opportunities and challenges," Nat
Rev Cancer, vol. 5, no. 3, pp. 161-71, Mar 2005.

[13]

M. Cutler, "Transillumination of the Breast," Ann Surg, vol. 93, no. 1, pp.
223-34, Jan 1931.

[14]

F. F. Jobsis, "Noninvasive infrared monitoring of cerebral and myocardial
sufficiency and circulatory parameters.," Science, vol. 198, pp. 1264-1267,
1977.

107

[15]

L. V. Wang, H. I. Wu, and W. Wang, Biomedical Optics: Principles And
Imaging. Wiley-Interscience, 2007.

[16]

V. Ntziachristos, A. G. Yodh, M. Schnall, and B. Chance, "Concurrent MRI
and diffuse optical tomography of breast after indocyanine green
enhancement," Proceedings of the National Academy of Sciences of the
United States of America, vol. 97, no. 6, pp. 2767-2772, MAR 14 2000.

[17]

A. Corlu et al., "Three-dimensional in vivo fluorescence diffuse optical
tomography of breast cancer in humans," (in eng), Opt Express, vol. 15, no.
11, pp. 6696-716, May 28 2007.

[18]

B. Alacam, B. Yazici, X. Intes, and B. Chance, "Analysis of ICG
Pharmacokinetics in Cancerous Tumors using NIR Optical Methods," Conf
Proc IEEE Eng Med Biol Soc, vol. 1, pp. 62-5, 2005.

[19]

X. D. Li, B. Chance, and A. G. Yodh, "Fluorescent heterogeneities in turbid
media: limits for detection, characterization, and comparison with
absorption," Applied Optics, vol. 37, no. 28, pp. 6833-6844, OCT 1 1998.

[20]

L. He, Y. Lin, C. Huang, D. Irwin, M. M. Szabunio, and G. Yu, "Noncontact
diffuse correlation tomography of human breast tumor," J Biomed Opt, vol.
20, no. 8, p. 86003, Aug 2015.

[21]

L. Dong et al., "Diffuse optical measurements of head and neck tumor
hemodynamics for early prediction of chemoradiation therapy outcomes," J
Biomed Opt, vol. 21, no. 8, p. 85004, Aug 1 2016.

108

[22]

T. Durduran, R. Choe, W. B. Baker, and A. G. Yodh, "Diffuse optics for
tissue monitoring and tomography," (in English), Reports on Progress in
Physics, vol. 73, no. 7, p. 076701, Jul 2010.

[23]

A. Yodh and B. Chance, "Spectroscopy and Imaging with Diffusing Light,"
Physics Today, vol. 48, no. 3, pp. 34-40, MAR 1995.

[24]

M. D. Reisman, Z. E. Markow, A. Q. Bauer, and J. P. Culver, "Structured
illumination

diffuse

optical

tomography

for

noninvasive

functional

neuroimaging in mice," Neurophotonics, vol. 4, no. 2, p. 021102, Apr 2017.
[25]

A. T. Eggebrecht et al., "Mapping distributed brain function and networks
with diffuse optical tomography," Nat Photonics, vol. 8, no. 6, pp. 448-454,
Jun 2014.

[26]

T. Durduran et al., "Transcranial optical monitoring of cerebrovascular
hemodynamics in acute stroke patients," (in eng), Opt Express, vol. 17, no.
5, pp. 3884-902, Mar 2 2009.

[27]

X. J. Gu, Q. Z. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. B. Jiang,
"Differentiation of cysts from solid tumors in the breast with diffuse optical
tomography," Academic Radiology, vol. 11, no. 1, pp. 53-60, JAN 2004.

[28]

V. Ntziachristos, "Going deeper than microscopy: the optical imaging
frontier in biology," (in English), Nature Methods, vol. 7, no. 8, pp. 603-614,
Aug 2010.

[29]

V. Ntziachristos, J. Ripoll, L. V. Wang, and R. Weissleder, "Looking and
listening to light: the evolution of whole-body photonic imaging," Nat
Biotechnol, vol. 23, no. 3, pp. 313-20, Mar 2005.

109

[30]

X. Intes, Ripoll, J., Chen, Y., Nioka, S., Yodh, A.G., Chance, B., "In vivo
continuous-wave optical breast imaging enhanced with Indocyanine
Green," Medical Physics, vol. 30, pp. 1039-1047, 2003.

[31]

D. J. Hawrysz and E. M. Sevick-Muraca, "Developments toward diagnostic
breast cancer imaging using near-infrared optical measurements and
fluorescent contrast agents," Neoplasia, vol. 2, no. 5, pp. 388-417., 2000.

[32]

S. Nioka et al., "Optical imaging of breast tumor by means of continuous
waves," Oxygen Transport to Tissue Xviii, vol. 411, pp. 227-232, 1997.

[33]

X. D. Li, Beauvoit, B., White, R., Nioka, S., Chance, B., and Yodh, A.G.,
"Tumor localization using fluorescence of indocyanine green (ICG) in rat
model," SPIE Proc., vol. 2389, p. 789, 1995.

[34]

V. Ntziachristos and R. Weissleder, "Experimental three-dimensional
fluorescence reconstruction of diffuse media by use of a normalized Born
approximation," Opt Lett, vol. 26, no. 12, pp. 893-5, Jun 15 2001.

[35]

K. Motomura, H. Inaji, Y. Komoike, T. Kasugai, S. Noguchi, and H. Koyama,
"Sentinel node biopsy guided by indocyanine green dye in breast cancer
patients," Jpn J Clin Oncol, vol. 29, no. 12, pp. 604-7, Dec 1999.

[36]

B. Ebert et al., "Near-infrared fluorescent dyes for enhanced contrast in
optical mammography: phantom experiments," J Biomed Opt, vol. 6, no. 2,
pp. 134-40., 2001.

[37]

V. R. Kondepati, H. M. Heise, and J. Backhaus, "Recent applications of
near-infrared spectroscopy in cancer diagnosis and therapy," (in eng), Anal
Bioanal Chem, vol. 390, no. 1, pp. 125-39, Jan 2008.

110

[38]

X. D. Li, M. A. O'Leary, D. A. Boas, B. Chance, and A. G. Yodh, "Fluorescent
diffuse photon density waves in homogeneous and heterogeneous turbid
media: analytic solutions and applications," Appl Opt, vol. 35, no. 19, pp.
3746-58, Jul 1 1996.

[39]

G. Yu, "Near-infrared diffuse correlation spectroscopy in cancer diagnosis
and therapy monitoring," J Biomed Opt, vol. 17, no. 1, p. 010901, Jan 2012.

[40]

R. Cheng, Y. Shang, D. Hayes, Jr., S. P. Saha, and G. Yu, "Noninvasive
optical evaluation of spontaneous low frequency oscillations in cerebral
hemodynamics," Neuroimage, vol. 62, no. 3, pp. 1445-54, Sep 2012.

[41]

Y. Shang et al., "Noninvasive evaluation of electrical stimulation impacts on
muscle hemodynamics via integrating diffuse optical spectroscopies with
muscle stimulator," J Biomed Opt, vol. 18, no. 10, p. 105002, Oct 1 2013.

[42]

G. Yu et al., "Time-dependent blood flow and oxygenation in human skeletal
muscles

measured

with

noninvasive

near-infrared

diffuse

optical

spectroscopies," J Biomed Opt, vol. 10, no. 2, p. 024027, Mar-Apr 2005.
[43]

K. Gurley, Y. Shang, and G. Yu, "Noninvasive optical quantification of
absolute blood flow, blood oxygenation, and oxygen consumption rate in
exercising skeletal muscle," J Biomed Opt, vol. 17, no. 7, p. 075010, Jul
2012.

[44]

Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, and G. Yu, "Portable optical
tissue flow oximeter based on diffuse correlation spectroscopy," (in eng),
Opt Lett, vol. 34, no. 22, pp. 3556-8, Nov 15 2009.

111

[45]

Y. Shang et al., "Noninvasive optical characterization of muscle blood flow,
oxygenation, and metabolism in women with fibromyalgia," Arthritis Res
Ther, vol. 14, no. 6, p. R236, Nov 1 2012.

[46]

Y. Shang, R. Cheng, L. Dong, S. J. Ryan, S. P. Saha, and G. Yu, "Cerebral
monitoring during carotid endarterectomy using near-infrared diffuse optical
spectroscopies and electroencephalogram," Phys Med Biol, vol. 56 pp.
3015-3032, 2011.

[47]

G. Yu, Y. Shang, Y. Zhao, R. Cheng, L. Dong, and S. P. Saha,
"Intraoperative evaluation of revascularization effect on ischemic muscle
hemodynamics using near-infrared diffuse optical spectroscopies," (in
English), J Biomed Opt, vol. 16, no. 2, p. 027004, Feb 2011.

[48]

Y. Shang, T. B. Symons, T. Durduran, A. G. Yodh, and G. Yu, "Effects of
muscle fiber motion on diffuse correlation spectroscopy blood flow
measurements during exercise," Biomed Opt Express, vol. 1, no. 2, pp. 500511, 2010.

[49]

G. Yu, T. Durduran, C. Zhou, R. Cheng, and A. Yodh, "Near-infrared diffuse
correlation spectroscopy (DCS) for assessment of tissue blood flow," in
Handbook of Biomedical Optics, D. Boas, C. Pitris, and N. Ramanujam,
Eds.: Taylor & Francis Books Inc, 2011, pp. 195-216.

[50]

R. Cheng, "Noninvasive near-infrared diffuse optical monitoring of cerebral
hemodynamics

and

autoregulation,"

Engineering, University of Kentucky, 2013.

112

Department

of

Biomedical

[51]

D. A. Boas, L. E. Campbell, and A. G. Yodh, "Scattering and imaging with
diffusing temporal field correlations," Phys Rev Lett, vol. 75, no. 9, pp. 18551858, AUG 28 1995.

[52]

R. Cheng et al., "Near-infrared diffuse optical monitoring of cerebral blood
flow and oxygenation for the prediction of vasovagal syncope," J Biomed
Opt, vol. 19, no. 1, p. 17001, Jan 2014.

[53]

L. Dong et al., "Noninvasive diffuse optical monitoring of head and neck
tumor blood flow and oxygenation during radiation delivery," Biomed Opt
Express, vol. 3, no. 2, pp. 259-72, Feb 1 2012.

[54]

U. Sunar et al., "Noninvasive diffuse optical measurement of blood flow and
blood oxygenation for monitoring radiation therapy in patients with head and
neck tumors: a pilot study," (in eng), J Biomed Opt, vol. 11, no. 6, p. 064021,
Nov-Dec 2006.

[55]

C. Menon et al., "An integrated clinically relevant approach to measuring
tumor oxygen status using VEGF-transfected human melanoma xenografts
as a model," Cancer Research, vol. 63, pp. 7232-7240, 2003.

[56]

T. M. Busch et al., "Fluence rate-dependent intratumor heterogeneity in
physiologic and cytotoxic responses to Photofrin photodynamic therapy," (in
English), Photochem Photobiol Sci, vol. 8, no. 12, pp. 1683-1693, 2009.

[57]

B. Henry et al., "Hybrid diffuse optical techniques for continuous
hemodynamic measurement in gastrocnemius during plantar flexion
exercise," J Biomed Opt, vol. 20, no. 12, p. 125006, 2015.

113

[58]

C. Zhou et al., "Diffuse optical monitoring of blood flow and oxygenation in
human breast cancer during early stages of neoadjuvant chemotherapy,"
(in eng), J Biomed Opt, vol. 12, no. 5, p. 051903, Sep-Oct 2007.

[59]

T. Durduran et al., "Diffuse optical measurement of blood flow in breast
tumors," (in eng), Opt Lett, vol. 30, no. 21, pp. 2915-7, Nov 1 2005.

[60]

G. Yu et al., "Noninvasive monitoring of murine tumor blood flow during and
after photodynamic therapy provides early assessment of therapeutic
efficacy," (in eng), Clin Cancer Res, vol. 11, no. 9, pp. 3543-52, May 1 2005.

[61]

G. Ramirez et al., "Chemotherapeutic drug-specific alteration of
microvascular blood flow in murine breast cancer as measured by diffuse
correlation spectroscopy," Biomed Opt Express, vol. 7, no. 9, pp. 36103630, Sep 1 2016.

[62]

J. D. Johansson et al., "Scanning, non-contact, hybrid broadband diffuse
optical spectroscopy and diffuse correlation spectroscopy system," Biomed
Opt Express, vol. 7, no. 2, pp. 481-98, Feb 1 2016.

[63]

D. A. Boas and A. G. Yodh, "Spatially varying dynamical properties of turbid
media probed with diffusing temporal light correlation," J Opt Soc Am A Opt
Image Sci Vis, vol. 14, no. 1, pp. 192-215, JAN 1997.

[64]

M. Schweiger, S. R. Arridge, M. Hiraoka, and D. T. Delpy, "The finite
element method for the propagation of light in scattering media: boundary
and source conditions," Med Phys, vol. 22, no. 11 Pt 1, pp. 1779-92, Nov
1995.

114

[65]

G. Yu, "Diffuse Correlation Spectroscopy (DCS): A Diagnostic Tool for
Assessing Tissue Blood Flow in Vascular-Related Diseases and
Therapies," (in English), Current Medical Imaging Reviews, vol. 8, no. 3, pp.
194-210, Aug 2012.

[66]

T. Durduran, "Non-invasive measurements of tissue hemodynamics with
hybrid diffuse optical methods," Ph.D. thesis, University of Pennsylvania,
Dissertation, 2004.

[67]

Y. Shang, L. Chen, M. Toborek, and G. Yu, "Diffuse optical monitoring of
repeated cerebral ischemia in mice," Opt Express, vol. 19, no. 21, pp.
20301-15, Oct 10 2011.

[68]

E. M. Buckley et al., "Cerebral hemodynamics in preterm infants during
positional intervention measured with diffuse correlation spectroscopy and
transcranial Doppler ultrasound," (in eng), Opt Express, vol. 17, no. 15, pp.
12571-81, Jul 20 2009.

[69]

N. Roche-Labarbe et al., "Noninvasive optical measures of CBV, StO(2),
CBF index, and rCMRO(2) in human premature neonates' brains in the first
six weeks of life," (in eng), Hum Brain Mapp, vol. 31, no. 3, pp. 341-52, Mar
2010.

[70]

M. N. Kim et al., "Noninvasive measurement of cerebral blood flow and
blood

oxygenation

using

near-infrared

and

diffuse

correlation

spectroscopies in critically brain-injured adults," (in eng), Neurocrit Care,
vol. 12, no. 2, pp. 173-80, Apr 2010.

115

[71]

G. Yu et al., "Validation of diffuse correlation spectroscopy for muscle blood
flow with concurrent arterial spin labeled perfusion MRI," Opt Express, vol.
15, no. 3, pp. 1064-1075 2007.

[72]

C. Zhou et al., "Diffuse optical monitoring of hemodynamic changes in piglet
brain with closed head injury," (in eng), J Biomed Opt, vol. 14, no. 3, p.
034015, May-Jun 2009.

[73]

S. O. Rice, "Mathematical analysis of random noise," in Noise and
Stochastic Processes, N. Wax, Ed. New York: Dover, 1954, p. 133.

[74]

L. Dong, L. He, Y. Lin, Y. Shang, and G. Yu, "Simultaneously extracting
multiple parameters via fitting one single autocorrelation function curve in
diffuse correlation spectroscopy," IEEE Trans Biomed Eng, vol. 60, no. 2,
pp. 361-8, Feb 2013.

[75]

L. He, Y. Lin, Y. Shang, B. J. Shelton, and G. Yu, "Using optical fibers with
different modes to improve the signal-to-noise ratio of diffuse correlation
spectroscopy flow-oximeter measurements," (in English), Journal of
Biomedical Optics, vol. 18, no. 3, Mar 2013.

[76]

R. Toy et al., "Multimodal in vivo imaging exposes the voyage of
nanoparticles in tumor microcirculation," ACS Nano, vol. 7, no. 4, pp. 311829, Apr 23 2013.

[77]

D. R. Busch et al., "Blood flow reduction in breast tissue due to
mammographic compression," Acad Radiol, vol. 21, no. 2, pp. 151-61, Feb
2014.

116

[78]

E. K. Chan, B. Sorg, D. Protsenko, M. O'Neil, M. Motamedi, and A. J. Welch,
"Effects of compression on soft tissue optical properties," Ieee Journal of
Quantum Electronics, vol. 2, no. 4, pp. 943-950, 1996.

[79]

S. A. Carp et al., "Compression-induced changes in the physiological state
of the breast as observed through frequency domain photon migration
measurements," J Biomed Opt, vol. 11, no. 6, p. 064016, Nov-Dec 2006.

[80]

J. Ripoll, R. B. Schulz, and V. Ntziachristos, "Free-space propagation of
diffuse light: Theory and experiments," Physical Review Letters, vol. 91, no.
10, pp. -, SEP 5 2003.

[81]

R. B. Schulz, J. Ripoll, and V. Ntziachristos, "Experimental fluorescence
tomography of tissues with noncontact measurements," (in English), Ieee
Transactions on Medical Imaging, vol. 23, no. 4, pp. 492-500, Apr 2004.

[82]

N. Deliolanis, T. Lasser, D. Hyde, A. Soubret, J. Ripoll, and V. Ntziachristos,
"Free-space fluorescence molecular tomography utilizing 360 degrees
geometry projections," Opt Lett, vol. 32, no. 4, pp. 382-4, Feb 15 2007.

[83]

N. C. Deliolanis, J. Dunham, T. Wurdinger, J. L. Figueiredo, B. A. Tannous,
and V. Ntziachristos, "In-vivo imaging of murine tumors using completeangle projection fluorescence molecular tomography," J Biomed Opt, vol.
14, no. 3, p. 030509, May-Jun 2009.

[84]

C. Zhou, G. Yu, D. Furuya, J. H. Greenberg, A. G. Yodh, and T. Durduran,
"Diffuse optical correlation tomography of cerebral blood flow during cortical
spreading depression in rat brain," Opt Express, vol. 14, pp. 1125-1144,
2006.

117

[85]

Y. Lin, C. Huang, D. Irwin, L. He, Y. Shang, and G. Yu, "Three-dimensional
flow contrast imaging of deep tissue using noncontact diffuse correlation
tomography," Appl Phys Lett, vol. 104, no. 12, p. 121103, Mar 24 2014.

[86]

J. P. Culver, T. Durduran, T. Furuya, C. Cheung, J. H. Greenberg, and A.
G. Yodh, "Diffuse optical tomography of cerebral blood flow, oxygenation,
and metabolism in rat during focal ischemia," J Cereb Blood Flow Metab,
vol. 23, no. 8, pp. 911-924, AUG 2003.

[87]

A. F. Fercher and J. D. Briers, "Flow Visualization by Means of SingleExposure Speckle Photography," (in English), Optics Communications, vol.
37, no. 5, pp. 326-330, 1981.

[88]

D. A. Boas and A. K. Dunn, "Laser speckle contrast imaging in biomedical
optics," J Biomed Opt, vol. 15, no. 1, p. 011109, Jan-Feb 2010.

[89]

J. D. Briers, "Laser Doppler, speckle and related techniques for blood
perfusion mapping and imaging," Physiol Meas, vol. 22, no. 4, pp. R35-66,
Nov 2001.

[90]

H. Cheng, Q. Luo, S. Zeng, S. Chen, J. Cen, and H. Gong, "Modified laser
speckle imaging method with improved spatial resolution," J Biomed Opt,
vol. 8, no. 3, pp. 559-64, Jul 2003.

[91]

R. Bi, J. Dong, and K. Lee, "Deep tissue flowmetry based on diffuse speckle
contrast analysis," Opt Lett, vol. 38, no. 9, pp. 1401-3, May 1 2013.

[92]

R. Bi, J. Dong, and K. Lee, "Multi-channel deep tissue flowmetry based on
temporal diffuse speckle contrast analysis," Opt Express, vol. 21, no. 19,
pp. 22854-22861, Sep 23 2013.

118

[93]

M. Seong et al., "Simultaneous blood flow and blood oxygenation
measurements using a combination of diffuse speckle contrast analysis and
near-infrared spectroscopy," J Biomed Opt, vol. 21, no. 2, p. 27001, Feb
2016.

[94]

C. P. Valdes, H. M. Varma, A. K. Kristoffersen, T. Dragojevic, J. P. Culver,
and T. Durduran, "Speckle contrast optical spectroscopy, a non-invasive,
diffuse optical method for measuring microvascular blood flow in tissue,"
Biomed Opt Express, vol. 5, no. 8, pp. 2769-84, Aug 1 2014.

[95]

H. M. Varma, C. P. Valdes, A. K. Kristoffersen, J. P. Culver, and T.
Durduran, "Speckle contrast optical tomography: A new method for deep
tissue three-dimensional tomography of blood flow," Biomed Opt Express,
vol. 5, no. 4, pp. 1275-89, Apr 1 2014.

[96]

C. Huang et al., "Noncontact diffuse optical assessment of blood flow
changes in head and neck free tissue transfer flaps," J Biomed Opt, vol. 20,
no. 7, p. 075008, Jul 2015.

[97]

Y. Lin, L. He, Y. Shang, and G. Yu, "Noncontact diffuse correlation
spectroscopy for noninvasive deep tissue blood flow measurement," J
Biomed Opt, vol. 17, no. 1, p. 010502, Jan 2012.

[98]

T. Li et al., "Simultaneous measurement of deep tissue blood flow and
oxygenation using noncontact diffuse correlation spectroscopy flowoximeter," Sci Rep, vol. 3, p. 1358, 2013.

[99]

C. Huang, Y. Lin, L. He, D. Irwin, M. M. Szabunio, and G. Yu, "Alignment of
sources and detectors on breast surface for noncontact diffuse correlation

119

tomography of breast tumors," Appl Opt, vol. 54, no. 29, pp. 8808-16, Oct
10 2015.
[100] C. Huang et al., "Noncontact 3-D Speckle Contrast Diffuse Correlation
Tomography of Tissue Blood Flow Distribution," IEEE Trans Med Imaging,
vol. 36, no. 10, pp. 2068-2076, Oct 2017.
[101] Y. Lin, C. Huang, D. Irwin, L. He, Y. Shang, and G. Yu, "Noncontact deep
tissue hemodynamic imaging using diffuse correlation tomography," ed.
Applied Physics Letters. Manuscript submitted for publication, 2013.
[102] D. A. Boas, "Diffuse photon probes of structural and dynamical properties
of turbid media: Theory and biomedical applications," Ph.D., University of
Pennsylvania, Dissertation, 1996.
[103] C. Zhou, "In-vivo optical imaging and spectroscopy of cerebral
hemodynamics," Ph.D. thesis, University of Pennsylvania, Dissertation,
2007.
[104] S. R. Arridge, "Optical Tomography in medical imaging," Inverse Problems,
vol. 15, pp. R41-R93, 1999.
[105] H. Dehghani et al., "Near infrared optical tomography using NIRFAST:
Algorithm for numerical model and image reconstruction," Commun Numer
Methods Eng, vol. 25, no. 6, pp. 711-732, Aug 15 2008.
[106] S. R. Arridge and M. Schweiger, "Photon-measurement density functions.
Part2: Finite-element-method calculations," Applied Optics, vol. 34, no. 34,
pp. 8026-8037, 1995.

120

[107] S. R. Arridge, M. Schweiger, M. Hiraoka, and D. T. Delpy, "A finite element
approach for modeling photon transport in tissue," Med.Phys., vol. 20, pp.
299-309, 1993.
[108] M. Schweiger, Arridge, S.R., and Delpy, D.T., "Application of the finiteelement method for the forward and inverse models in optical tomography,"
Journal of Mathematical Imaging and Vision, vol. 3, pp. 263-283, 1993.
[109] M. Schweiger, "Application of the Finite Element Method in Infrared Image
Reconstruction of Scattering Media," PhD, Department of Medical Physics
and Bioengineering, University College London, 1994.
[110] M. Jermyn et al., "Fast segmentation and high-quality three-dimensional
volume mesh creation from medical images for diffuse optical tomography,"
J Biomed Opt, vol. 18, no. 8, p. 86007, Aug 2013.
[111] S. R. Arridge, "Photon-measurement density functions. Part 1: Analytical
forms," Applied Optics, vol. 34, no. 31, pp. 7395-7409, 1995.
[112] L. He, "Noncontact Diffuse Correlation Tomography of Breast Tumor," PhD,
Biomedical Engineering, University of Kentucky, Lexington, KY, 2015.
[113] D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L.
Mcguire, "Human-Breast Cancer - Correlation of Relapse and Survival with
Amplification of the Her-2 Neu Oncogene," (in English), Science, vol. 235,
no. 4785, pp. 177-182, Jan 9 1987.
[114] A. McCann, P. A. Johnston, P. A. Dervan, W. J. Gullick, and D. N. Carney,
"c-erB-2 oncoprotein expression in malignant and nonmalignant breast
tissue," Ir J Med Sci, vol. 158, no. 6, pp. 137-40, Jun 1989.

121

[115] M. C. Paterson et al., "Correlation between C-Erbb-2 Amplification and Risk
of Recurrent Disease in Node-Negative Breast-Cancer," (in English),
Cancer Research, vol. 51, no. 2, pp. 556-567, Jan 15 1991.
[116] C. Ma, H. Lin, S. S. Leonard, X. Shi, J. Ye, and J. Luo, "Overexpression of
ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of
human mammary epithelial and breast cancer cells in vitro," Oncogene, vol.
22, no. 34, pp. 5281-90, Aug 14 2003.
[117] S. Wang et al., "Ethanol promotes mammary tumor growth and
angiogenesis: the involvement of chemoattractant factor MCP-1," Breast
Cancer Res Treat, vol. 133, no. 3, pp. 1037-48, Jun 2012.
[118] D. Irwin et al., "Influences of tissue absorption and scattering on diffuse
correlation spectroscopy blood flow measurements," Biomed Opt Express,
vol. 2, no. 7, pp. 1969-1985, 2011.
[119] H. W. Wang et al., "Treatment-induced changes in tumor oxygenation
predict photodynamic therapy outcome," (in eng), Cancer Res, vol. 64, no.
20, pp. 7553-61, Oct 15 2004.
[120] T. Durduran et al., "Bulk optical properties of healthy female breast tissue,"
Physics in Medicine and Biology, vol. 47, no. 16, pp. 2847-2861, AUG 21
2002.
[121] S. L. Jacques, "Optical properties of biological tissues: a review," Phys Med
Biol, vol. 58, no. 11, pp. R37-61, Jun 7 2013.

122

[122] A. D. Krainov, A. M. Mokeeva, E. A. Sergeeva, P. D. Agrba, and M. Y.
Kirillin, "Optical properties of mouse biotissues and their optical phantoms,"
Optics and Spectroscopy, vol. 115, no. 2, pp. 193-200, 2013.
[123] Y. Shang, T. Li, L. Chen, Y. Lin, M. Toborek, and G. Yu, "Extraction of
diffuse correlation spectroscopy flow index by integration of th-order linear
model with Monte Carlo simulation," Appl Phys Lett, vol. 104, no. 19, p.
193703, May 12 2014.
[124] Y. Shang and G. Yu, "A Nth-order linear algorithm for extracting diffuse
correlation spectroscopy blood flow indices in heterogeneous tissues," Appl
Phys Lett, vol. 105, no. 13, p. 133702, Sep 29 2014.
[125] C. Huang et al., "Speckle contrast diffuse correlation tomography of
complex turbid medium flow," Med Phys, vol. 42, no. 7, pp. 4000-6, Jul
2015.
[126] C. Huang et al., "Low-cost compact diffuse speckle contrast flowmeter using
small laser diode and bare charge-coupled-device," J Biomed Opt, vol. 21,
no. 8, p. 80501, Aug 1 2016.
[127] S. J. Kirkpatrick, D. D. Duncan, and E. M. Wells-Gray, "Detrimental effects
of speckle-pixel size matching in laser speckle contrast imaging," Opt Lett,
vol. 33, no. 24, pp. 2886-8, Dec 15 2008.
[128] R. Bandyopadhyay, A. S. Gittings, S. S. Suh, P. K. Dixon, and D. J. Durian,
"Speckle-visibility spectroscopy: A tool to study time-varying dynamics," (in
English), Review of Scientific Instruments, vol. 76, no. 9, Sep 2005.

123

[129] W. Ruyten, "Smear correction for frame transfer charge-coupled-device
cameras," Opt Lett, vol. 24, no. 13, pp. 878-80, Jul 1 1999.
[130] S. Yuan, "Sensitivity, noise and quantitative model of laser speckle contrast
imaging," PhD PhD Thesis, PhD Thesis, Tufts University, Medford, MA,
2008.
[131] S. Yuan, A. Devor, D. A. Boas, and A. K. Dunn, "Determination of optimal
exposure time for imaging of blood flow changes with laser speckle contrast
imaging," Appl Opt, vol. 44, no. 10, pp. 1823-30, Apr 1 2005.
[132] D. D. Duncan, S. J. Kirkpatrick, and R. K. Wang, "Statistics of local speckle
contrast," J Opt Soc Am A Opt Image Sci Vis, vol. 25, no. 1, pp. 9-15, Jan
2008.
[133] M. Watanabe and S. K. Nayar, "Telecentric optics for focus analysis," (in
English), Ieee Transactions on Pattern Analysis and Machine Intelligence,
vol. 19, no. 12, pp. 1360-1365, Dec 1997.
[134] L. Zhang, H. Zhao, W. B. Dong, N. Cao, and P. F. Zhang, "Design of an
optical system consisting of a special telecentric lens for side-scattering
measurement on individual cells," Optical Engineering, vol. 49, no. 5, 2010.
[135] B. Yuan, N. Chen, and Q. Zhu, "Emission and absorption properties of
indocyanine green in Intralipid solution," J Biomed Opt, vol. 9, no. 3, pp.
497-503, May-Jun 2004.
[136] S. C. Davis, H. Dehghani, J. Wang, S. Jiang, B. W. Pogue, and K. D.
Paulsen,

"Image-guided

diffuse

124

optical

fluorescence

tomography

implemented with Laplacian-type regularization," Opt Express, vol. 15, no.
7, pp. 4066-82, Apr 2 2007.
[137] M. Doulgerakis, A. Eggebrecht, J. Culver, and H. Dehghani, "Towards realtime functional human brain imaging with diffuse optical tomography," in
Proc. of SPIE-OSA, CA, 2017, vol. 10412, p. 1041209.
[138] X. Wu, A. T. Eggebrecht, S. L. Ferradal, J. P. Culver, and H. Dehghani,
"Fast and efficient image reconstruction for high density diffuse optical
imaging of the human brain," Biomed Opt Express, vol. 6, no. 11, pp. 456784, Nov 1 2015.

125

VITA

Daniel Irwin, Ph.D. Candidate

EDUCATION
University of Louisville, Louisville, Kentucky, USA
B.S., Computer Science and Computer Engineering, June 2008

University of Kentucky, Lexington, Kentucky, USA
M.S., Biomedical Engineering, December 2011

University of Kentucky, Lexington, Kentucky, USA
Ph.D. Candidate, Biomedical Engineering, August 2012 – present

PROFESSIONAL POSITIONS
Research Assistant (Biophotonics), Department of Biomedical Engineering,
University of Kentucky, Lexington, KY, 2009 – present

Research Assistant (Cardiovascular), Department of Biomedical Engineering,
University of Kentucky, Lexington, KY, 2010 – 2011

PROFESSIONAL MEMBERSHIPS
Optical Society of America (OSA), 2012 – 2017
Biomedical Engineering Society (BMES), 2010 – 2017

126

HONORS AND ACTIVITIES
Cancer Nano. Training Center (CNTC) Predoctoral Traineeship, 2013 – 2015
($25,775 Supply Funding; $30,000 Annual Stipend; $3,200 Travel Funding)
CNTC & Markey Cancer Center Joint Seminar, 2014
JOSA-A Manuscript Peer Reviewer, 2014
Visiting Student Mentor, 2014
Assist Rehabilitation Sciences Group Integrate LabVIEW Program, 2014
BME 530 LabVIEW/Project Introductory Lecture and Lab Assistant, 2013 – 2016
University of Kentucky BME Fall Newsletter Student Spotlight, 2013
Fundamentals of Engineering Exam Completion, 2013
Grant Proposal Feedback (Multiple Departments), 2012 – present
Engineers Day (E-Day) Volunteer, 2009 – 2011, 2015
Student Travel Support Award, University of Kentucky, 2011
Lab Liaison, 2010 – 2017

PUBLICATIONS
Peer-reviewed Papers
1. C. Huang, D. Irwin, M. Zhao, Y. Shang, N. B. Agochukwu, L. Wong, G. Yu,
“Noncontact 3-dimensional speckle contrast diffuse correlation tomography
of tissue blood flow distribution,” IEEE Transactions on Medical Imaging 36
(10), (2017)
2. L. Dong, M. Kudrimoti, D. Irwin, L. Chen, S. Kumar, Y. Shang, C. Huang,
E. L. Johnson, S. D. Stevens, B. J. Shelton, G. Yu, “Diffuse optical

127

measurements of head and neck tumor hemodynamics for early prediction
of chemoradiation therapy outcomes,” JBO 21(8), 085004 (2016)
3. C. Huang*, D. Irwin*, Y. Lin, Y. Shang, L. He, W. Kong, J. Luo, G. Yu,
“Speckle contrast diffuse correlation tomography of complex turbid medium
flow,” Medical Physics Letter 42(7), 4000 (2015). *Contributed equally
4. C. Huang, Y. Lin, L. He, D. Irwin, M. Szabunio, G. Yu, “Alignment of sources
and detectors on breast surface for noncontact diffuse correlation
tomography of breast tumors,” Appl Opt 54(29), 8808-8816 (2015)
5. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “Noncontact diffuse
correlation tomography of human breast tumor,” JBO 20(8), 086003 (2015)
6. Y. Lin, C. Huang, D. Irwin, L. He, Y. Shang, G. Yu, “Three-dimensional flow
contrast imaging of deep tissue using noncontact diffuse correlation
tomography,” Appl Phys Lett 104(12), 121103 (2014)
7. D. Irwin, L. Dong, Y. Shang, R. Cheng, M. Kudrimoti, S. D. Stevens, G. Yu,
“Influences of tissue absorption and scattering on diffuse correlation
spectroscopy blood flow measurements,” Biomedical Optics Express 2,
1969-1985 (2011)
8. Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, G. Yu, “Portable optical
tissue flow oximeter based on diffuse correlation spectroscopy,” Optics
Letters 34(22), 3556-3558 (2009)

128

Conference Abstracts/Proceedings
1. D. Irwin, C. Huang, M. Zhao, S. Mazdeyasna, A. Bahrani, G. Yu,
“Noncontact optical imaging of flow and fluorescence contrasts,” University
of Kentucky Center for Clinical and Translational Science 13 th Annual
Spring Conference, Lexington, KY, USA (2018)
2. M. Zhao, C. Huang, D. Irwin, S. Mazdeyasna, N. Agochukwu, R. Li, L.
Wong, G. Yu, “Noncontact 3-dimensional speckle contrast diffuse
correlation tomography of tissue blood flow distribution,” Biomedical
Engineering Society Annual Meeting, Phoenix, AZ, USA (2017)
3. D. Irwin*, C. Huang*, Y. Lin, Y. Shang, L. He, W. Kong, J. Luo, G. Yu,
“Speckle contrast diffuse correlation tomography (scDCT): A reflectancebased FEM technique for flow contrast imaging of complex turbid media,”
Biomedical Engineering Society Annual Meeting, Tampa, FL, USA (2015),
* Equal contributors
4. L. Dong, D. Irwin, Y. Shang, L. Chen, B. Shelton, S. Stevens, M. Kudrimoti,
G. Yu, “Diffuse optical measurements of head and neck tumor
hemodynamics for early prediction of radiation therapy outcomes,”
Biomedical Engineering Society Annual Meeting, Tampa, FL, USA (2015)
5. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “Noncontact diffuse
correlation tomography of human breast tumor,” Biomedical Engineering
Society Annual Meeting, Tampa, FL, USA (2015)
6. D. Irwin*, C. Huang*, Y. Lin, Y. Shang, L. He, W. Kong, J. Luo, G. Yu,
“Speckle contrast diffuse correlation tomography for flow contrast imaging

129

of complex turbid media,” Markey Cancer Center Research Day, Lexington,
KY, USA (2015), * Equal contributors
7. L. Dong, M. Kudrimoti, D. Irwin, L. Chen, Y. Shang, X. Li, S. D. Stevens, B.
J. Shelton, G. Yu, “Diffuse optical measurements of head and neck tumor
hemodynamics for early prediction of radiation therapy,” Markey Cancer
Center Research Day, Lexington, KY, USA (2015)
8. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “Noncontact diffuse
optical 3-D imaging of hemodynamic contrasts in breast tumor: Computer
simulation,” Markey Cancer Center Research Day, Lexington, KY, USA
(2015)
9. D. Irwin*, C. Huang*, Y. Lin, Y. Shang, L. He, W. Kong, J. Luo, G. Yu,
“Speckle contrast diffuse correlation tomography for flow contrast imaging
of complex turbid media,” University of Kentucky Center for Clinical and
Translational Science 10th Annual Spring Conference, Lexington, KY, USA
(2015), * Equal contributors
10. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “Noncontact diffuse
optical 3-D imaging of hemodynamic contrasts in breast tumor: Computer
simulation,” University of Kentucky Center for Clinical and Translational
Science 10th Annual Spring Conference, Lexington, KY, USA (2015)
11. D. Irwin, Y. Lin, C. Huang, L. He, Y. Shang, M. Xu, H. Wang, J. Luo, G. Yu,
“3-D Blood Flow Contrast Imaging Case Study on Small Animal Mammary
Tumors Using Noncontact Diffuse Correlation Tomography (ncDCT),”

130

University of Kentucky Center for Clinical and Translational Science 9th
Annual Spring Conference, Lexington, KY, USA (2014)
12. D. Irwin, Y. Lin, C. Huang, L. He, Y. Shang, M. Xu, H. Wang, J. Luo, G. Yu,
"Noncontact Near-Infrared 3-D Blood Flow Contrast Imaging on Small
Animal Mammary Tumors: A Case Study," OSA BIOMED, Miami, FL, USA
(2014)
13. D. Irwin, Y. Lin, C. Huang, L. He, Y. Shang, M. Xu, H. Wang, J. Luo, G. Yu,
“A Case Study on Mouse Mammary Tumor Blood Flow Contrast Imaging
with 3-D Noncontact Diffuse Correlation Tomography,” Markey Cancer
Center Research Day, Lexington, KY, USA (2014)
14. Y. Lin, C. Huang, D. Irwin, L. He, Y. Shang, G. Yu, “Noncontact threedimensional flow contrast imaging of deep tissue using diffuse correlation
tomography,” OSA BIOMED, Miami, FL, USA (2014)
15. Y. Lin, C. Huang, D. Irwin, L. He, Y. Shang, G. Yu, “Three-dimensional flow
contrast imaging of deep tissue using noncontact diffuse correlation
tomography (ncDCT),” University of Kentucky Center for Clinical and
Translational Science 9th Annual Spring Conference, Lexington, KY, USA
(2014)
16. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “3-D blood flow
imaging of breast tumor using noncontact diffuse correlation tomography
(ncDCT): Computer simulations,” University of Kentucky Center for Clinical
and Translational Science 9th Annual Spring Conference, Lexington, KY,
USA (2014)

131

17. L. Dong, M. Kudrimoti, D. Irwin, C. Huang, Y. Shang, J. Bruno, S. D.
Stevens, B. J. Shelton, G. Yu, “Diffuse optical measurements of head and
neck tumor hemodynamics for early prediction of radiation therapy,” Markey
Cancer Center Research Day, Lexington, KY, USA (2014)
18. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “Noncontact diffuse
correlation tomography (ncDCT) for 3-D blood flow imaging of breast
tumor,” Markey Cancer Center Research Day, Lexington, KY, USA (2014)
19. C. Huang, Y. Lin, L. He, D. Irwin, G. Yu, “A computer-aided-design
approach to align sources and detectors on arbitrary tissue surface for
noncontact diffuse correlation tomography,” OSA BIOMED, Miami, FL, USA
(2014)
20. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “3-D blood flow
imaging of breast tumor using noncontact diffuse correlation tomography:
computer simulations,” OSA BIOMED, Miami, FL, USA (2014)
21. Y. Lin, C. Huang, L. He, D. Irwin, Y. Shang, G. Yu, “Three-dimensional flow
contrast imaging of deep tissue tumor using noncontact diffuse correlation
tomography (ncDCT),” Markey Cancer Center Research Day, Lexington,
KY, USA (2014)
22. D. Irwin, Y. Lin, L. He, C. Huang, Y. Shang, M. Zhao, G. Yu, “Noncontact
3-D imaging of small animal tumors with combined diffuse optical,
correlation, and fluorescence tomography: preliminary results in phantoms,”
in Markey Cancer Center Research Day, Lexington, KY, USA (2013)

132

23. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “Noncontact diffuse
optical 3-D imaging of hemodynamic contrasts in breast tumor: computer
simulation,” in Markey Cancer Center Research Day, Lexington, KY, USA
(2013)
24. C. Huang, Y. Lin, L. He, Y. Shang, D. Irwin, M. Szabunio, G. Yu,
“Noncontact diffuse optical 3-D imaging of hemodynamic contrasts in breast
tumor: geometrical reconstruction and alignment of optical sources and
detectors,” in Markey Cancer Center Research Day, Lexington, KY, USA
(2013)
25. D. Irwin, Y. Lin, L. He, C. Huang, Y. Shang, M. Zhao, G. Yu, “Noncontact
3-D imaging of small animal tumors with combined diffuse optical,
correlation, and fluorescence tomography: preliminary results in phantoms,”
in University of Kentucky Center for Clinical and Translational Science 8th
Annual CCTS Spring Conference, Lexington, KY, USA (2013)
26. L. He, Y. Lin, C. Huang, D. Irwin, M. Szabunio, G. Yu, “Noncontact diffuse
optical 3-D imaging of hemodynamic contrasts in breast tumor: computer
simulation,” in University of Kentucky Center for Clinical and Translational
Science 8th Annual CCTS Spring Conference, Lexington, KY, USA (2013)
27. C. Huang, Y. Lin, L. He, Y. Shang, D. Irwin, M. Szabunio, G. Yu,
“Noncontact diffuse optical 3-D imaging of hemodynamic contrasts in breast
tumor: geometrical reconstruction and alignment of optical sources and
detectors,” in University of Kentucky Center for Clinical and Translational
Science 8th Annual CCTS Spring Conference, Lexington, KY, USA (2013)

133

28. L. Dong, D. Irwin, Y. Shang, R. Cheng, M. Kudrimoti, S. D. Stevens, G. Yu,
“Influences of tissue optical properties on diffuse correlation spectroscopy
blood flow measurements,” in OSA Biomedical Optics (BIOMED), Miami,
FL, USA (2012)
29. D. Irwin, L. Dong, Y. Shang, R. Cheng, M. Kudrimoti, S. D. Stevens, G. Yu,
“Influences of tissue absorption and scattering on diffuse correlation
spectroscopy blood flow measurements in head and neck tumors,” in
Advances in Optics for Biotechnology, Medicine and Surgery XII, ECI
Conferences, Naples, FL, USA (2011)
30. D. Irwin, L. Dong, Y. Shang, R. Cheng, M. Kudrimoti, S. D. Stevens, G. Yu,
“Influences of tissue absorption and scattering on diffuse correlation
spectroscopy blood flow measurements in head and neck tumors,” in
Markey Cancer Center Research Day, Lexington, KY, USA (2011)
31. Y. Shang, R. Cheng, L. Dong, D. Irwin, K. M. Gurley, K. R. Swartz, S. S.
Salles, G. Yu, “Evaluation of electronic stimulation impact on muscle
hemodynamics using diffuse optical spectroscopies,” in 23rd Annual
Physical Medicine and Rehabilitation Research Day, Lexington, KY, USA
(2011)
32. Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, K. R. Swartz, S. S. Salles,
G. Yu, “Diffuse optical spectroscopies for evaluation of muscle
hemodynamic enhancements by electrical stimulation,” in OSA Biomedical
Optics (BIOMED), Miami, FL, USA (2010)

134

33. G. Yu, Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, S. P. Saha,
“Portable optical tissue flow oximeter for evaluation of revascularization
effect on ischemic muscle hemodynamics,” in OSA Biomedical Optics
(BIOMED), Miami, FL, USA (2010)
34. Y. Shang, Y. Zhao, R. Cheng, L. Dong, D. Irwin, K. R. Swartz, S. S. Salles,
G. Yu, “Diffuse optical spectroscopies for evaluation of muscle
hemodynamic enhancements by electrical stimulation,” in Muscle Biology
Fall Retreat, Lexington, KY, USA (2010)
35. G. Yu, Y. Zhao, R. Cheng, L. Dong, D. Irwin, “A portable optical tissue flow
oximeter based on diffuse correlation spectroscopy,” in BiOS SPIE
Photonics West, San Francisco, CA, USA (2010)
36. Y. Shang, Y. Zhao, R. Cheng, D. Irwin, L. Dong, K. R. Swartz, S. S. Salles,
G. Yu, “Noninvasive assessment of muscle hemodynamic enhancement by
electrical stimulation using diffuse optical spectroscopies,” in Fall Annual
Meeting of the Biomedical Engineering Society, Pittsburgh, PA, USA (2009)
37. G. Yu, Y. Shang, Y. Zhao, R. Cheng, D. Irwin, L. Dong, K. R. Swartz, and
S. S. Salles, “Diffuse optical evaluation of muscle hemodynamic responses
to electrical stimulation,” in 2nd Photonics and OptoElectronics Meetings,
Wuhan, China (2009)
38. Y. Shang, Y. Zhao, R. Cheng, D. Irwin, L. Dong, K. R. Swartz, S. S. Salles,
G. Yu, “Noninvasive assessment of muscle hemodynamic enhancement by
electrical stimulation using diffuse optical spectroscopies,” in Adult Skeletal

135

Muscle Symposium: Clinical Problems, Molecular Targets, Lexington, KY,
USA (2009)
39. Y. Shang, Y. Zhao, R. Cheng, D. Irwin, L. Dong, K. R. Swartz, S. S. Salles,
G. Yu, “Noninvasive assessment of muscle hemodynamic enhancement by
electrical stimulation using diffuse optical spectroscopies,” in Linda and
Jack Gill Heart Institute Cardiovascular Research Day, Lexington, KY, USA
(2009)

136

